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ABSTRACT 
 
Chaitanya Prakash Puranik: Effect of Fluoride on Parathyroid Hormone Secretion 
 
(Under the direction of Eric Everett) 
 
Systemic fluoride induces osteoclastogenesis in C3H/HeJ (C3H) mice with 
increased serum iPTH, sRANKL, and TRAP5b along with reduced levels of OPG; 
whereas, in C57BL/6J (B6) mice fluoride has anabolic actions (Yan et al 2007). In 
humans pseudo-hyperparathyroidism is sometimes seen with skeletal fluorosis. 
Early events of fluoride’s actions on the parathyroid gland are not well understood. 
Objective: This study investigated fluoride’s effects on iPTH secretion and its 
underlying mechanism. Methods: In vitro: Thryo-parathyroid complexes (TPC) from 
5-6 week old C3H (n=18) and B6 (n=18) male mice were dissected and dispersed. 
TPC were cultured in medium pre-optimized for calcium, phosphorus, and 
magnesium levels equivalent to mouse serum levels. TPC were treated with 0, 250 
or 500µM [F-] for 24hrs and secreted iPTH levels determined by ELISA. HEK293T-
cloned cells (containing luciferase reporter) were transfected with human calcium 
sensing receptor (CASR) or orphan GPCRs followed by 0 or 1mM fluoride treatment 
(16hrs) to determine β-arrestin recruitment. In vivo: 5-6 week old C3H (n=78) and 
B6 (n=78) male mice were gavaged with distilled or fluoride water (1µg [F-]/g-body 
weight). Serum iPTH, calcium, phosphorus, magnesium, and fluoride were 
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determined at 0, 3, 6, 12, or 24hrs. Results: A dose-dependent decrease in 
secreted iPTH was seen in vitro for C3H (p<0.005) and B6 (p<0.005) at 500µM [F-] 
exposure. Single gavage led to an increase in serum fluoride peaking at 0.5hr. iPTH 
also peaked at 0.5hr in both C3H (p=0.002) and B6 (p=0.01) followed by a decrease 
in C3H at 24hrs (p=0.002) returning to baseline at 48hrs. At 12hrs, there was an 
increase in iPTH in B6 (p<0.001) which returned to baseline at 24hrs. Fluoride 
treatment did not alter β-arrestin recruitment by CASR. GPR111, GPR142 and 
GPRC5D demonstrated increased β-arrestin recruitment. Conclusion: Fluoride 
modulates iPTH secretion in vitro and in vivo. However, Fluoride’s action on the 
parathyroid gland is not mediated through CASR. While fluoride’s effects, in vitro, 
were equivalent between the two mouse strains, early strain-dependent effect on 
iPTH secretion was observed in vivo. Difference in fluoride-mediated gene 
expression in C3H and B6 suggests an underlying difference in physiologic handling 
of fluoride by the two strains.  
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CHAPTER 1: REVIEW OF LITERATURE 
1.1 Fluoride 
1.1.1 Introduction 
Fluorine is the 13th most abundant element found in the earth’s crust (Fordyce et 
al., 2007). Due to the small radius of the fluorine atom, its effective surface charge is 
the highest among all elements. As a consequence, fluorine is the most 
electronegative element and seldom occurs in nature in an elemental form. It is 
found frequently as inorganic fluoride that is widely distributed (Ekstrand, 1978). 
Fluorine exists in nature in compound forms such as: fluorite (CaF2), fluorapatite 
(Ca5(PO4)3F), and cryolite (Na2AlF6). Higher concentrations of fluoride are found in 
dust, air, soil, rocks and surface ground water in the areas with recent or past 
geologic and pyroclastic activities or geologic uplifts (Everett, 2011). Presence of 
fluoride in surface and ground water is a major source of exposure to humans. 
Fluoride is also present in many processed food and drinks we consume. Soft drinks 
and fruit juices account for 75% of the fluoride intake in the United States. Fluorides 
as polytetrafluoroethyleneare (PTFE) are widely used in industrial processes for 
non-stick coatings. Fluoride has been used as an enzyme inhibitor in the past by 
biochemists in millimolar (mM) concentrations. Sodium fluoride is used as a general 
inhibitor of serine proteases and phosphatases. Fluoride can demonstrate two 
biologic actions (biphasic) based on its concentrations: mitogenic (inducing mitosis) 
at low concentrations and toxic at higher concentrations.  
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1.1.2 Metabolism 
Ingested fluoride is primarily absorbed from the stomach and intestine. Fluoride 
ion can complex with calcium ion to form fluorite (CaF2) (Kanbur et al., 2009). In the 
body, fluoride can combine with various elements to form insoluble complexes which 
can accumulate in the extracellular compartments (Mittal and Flora, 2006). Fluoride 
absorption (stomach and intestine), distribution (hard and soft tissue) and excretion 
(kidney) are pH dependent process. Hydrofluoric acid (HF) is a weak acid having an 
acid dissociation constant (pKa) of 3.4. Therefore at 3.4 pH, 50% of fluoride exists as 
un-dissociated form (HF) while the remaining 50% is in the dissociated or ionic form 
[F-]. When pH decreases from 3.4, the concentration of HF increases and when pH 
increases above 3.4, the concentration of [F-] increases (Whitford, 1996). HF has a 
high coefficient of permeability as compared to fluoride and hence HF can penetrate 
lipid bilayer more easily (Gutknecht and Walter, 1981). HF movement occurs in 
response to a pH gradient between body compartments (HF moves from the acidic 
compartment to the alkaline compartment along the pH gradient).  
Plasma fluoride concentrations rise rapidly after absorption of fluoride (as HF) 
through the stomach (Whitford, 1996). Fluoride that is not absorbed from the 
stomach is absorbed from the intestine. However, unlike gastric absorption, 
intestinal absorption of fluoride is independent of pH (Nopakun et al., 1989). Fluoride 
which is not absorbed from the stomach or intestine is excreted in the feces 
(Whitford, 1996). 
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Plasma fluoride concentrations reach peak after ingestion within 20-60 minutes 
(Whitford, 1996). The fluoride is then deposited in the newly mineralized tissues or is 
excreted through urine. In adults, approximately half of the absorbed fluoride is 
deposited in the mineralized tissues (bone, enamel, and dentin). Mineralized tissue 
holds approximately 99% of body’s fluoride (Whitford, 1994). However, fluoride is not 
irreversibly bound to bone. Fluoride can be released back into the plasma during 
bone remodeling (Whitford, 2008). A small fraction of fluoride absorbed is found in 
soft tissues (Whitford, 1984). Most of the absorbed fluoride, not taken up by 
mineralized tissues, is excreted in urine. Very small fraction (<1%) of absorbed 
fluoride is excreted in sweat and feces. The plasma fluoride concentrations return to 
the baseline after 3-6 hours (Whitford, 1996). 
 
1.1.2.1 Absorption 
More than 80% of the ingested fluoride is absorbed from gastro-intestinal (GI) 
tract. (Whitford, 1996). Presence of high amounts of bi- and tri-valent cations 
(calcium, magnesium, and aluminum) which form insoluble complexes with fluoride 
reduces net fluoride absorption. (Whitford, 1996). Although fluoride absorption from 
the stomach occurs rapidly, the rate of absorption is determined by gastric acidity 
(Messer and Ophaug, 1993; Whitford and Pashley, 1984) and velocity of gastric 
emptying (Messer and Ophaug, 1991; Nopakun et al., 1989).  
Fluoride absorption and gastric pH are inversely related. When the acidity of the 
stomach decreases (antacid administration) then the absorption of the fluoride 
decreases (Whitford and Pashley, 1984). When ionic fluoride enters the acidic 
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gastric lumen, it is converted into HF which is an uncharged molecule that can 
readily cross the gastric mucosa. Higher the acidity of the gastric content, faster will 
be the fluoride absorption from the stomach.  
Additionally, gastric emptying interferes with gastric fluoride absorption. Animal 
studies have shown that delayed gastric emptying might result in slower and smaller 
increases in plasma fluoride levels (Messer and Ophaug, 1991; Nopakun et al., 
1989). More than half of the fluoride which escapes gastric absorption is absorbed in 
the proximal part of small intestine (Nopakun et al., 1989). The small intestine has a 
huge capacity for fluoride absorption and fluoride is rapidly absorbed following 
emptying from the stomach. Ionic fluoride crosses the leaky epithelia through tight 
junctions between the paracellular channels (Nopakun et al., 1989). Fluoride 
absorption from the small intestine compensates for the low gastric absorption due 
to high pH to ensure that overall fluoride absorption is relatively unaffected by gastric 
pH (Messer and Ophaug, 1993; Whitford and Pashley, 1984). 
 
1.1.2.2 Distribution 
Plasma is the central compartment for fluoride distribution. Fluoride achieves 
steady-state distribution in the soft tissues where less than 1% of absorbed fluoride 
is present. More than half of absorbed fluoride is taken up by the calcified tissues, 
where fluoride is reversibly bound, and can be released back into the plasma in case 
of demand. (Whitford, 1994).  
Fluoride occurs in plasma in ionic and non-ionic forms. In the blood, ionic fluoride 
is not equally distributed between plasma and blood cells. Concentration of fluoride 
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in the plasma is twice as high as that found in the blood cells. The biological function 
of non-ionic fluoride has not been established yet. However, its concentration is 
usually higher than that of ionic fluoride. The non-ionic and ionic fluoride together 
constitute the total plasma fluoride (Whitford, 1996). Ionic fluoride concentrations in 
the plasma are dynamic; it depends on the amount of fluoride intake, 
deposition/removal (in/from soft and hard tissues), and urinary excretion (Whitford, 
1996). Therefore, plasma fluoride levels have been used as ‘contemporary 
biomarkers’ of fluoride exposure.  
 
1.1.2.2.1 Distribution in the soft tissues 
Fluoride in plasma is rapidly distributed to various tissues of the body. The rate of 
blood flow to the different tissues determines the distribution kinetics of fluoride 
(Whitford, 1996). When considering fluoride distribution the in soft tissues, it is 
important to note that fluoride, as HF, accumulates in the alkaline compartment in 
response to a pH gradient. The intracellular compartment is usually more acidic than 
extracellular and therefore, fluoride concentrations are typically lower in the 
intracellular compartment compared to those present in the plasma or extracellular 
compartment. In cases of acute fluoride poisoning, wherein toxic levels of fluoride 
are ingested, alkalization of the body fluids to promote a net efflux of intracellular 
fluoride is a recommended treatment.   
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1.1.2.2.2 Distribution in body fluids 
Fluoride concentrations in body fluids are dynamic and different from those found 
in plasma. Cerebrospinal fluid and milk have fluoride concentrations 50% lower than 
that of plasma. Gingival crevicular fluid and ductal saliva (submandibular and 
parotid) fluoride levels are slightly higher and lower, respectively, than those in 
plasma. Reported ratio of fluoride concentrations in ductal saliva to plasma fluoride 
concentrations are around 0.9 and 0.8 for submandibular and parotid secretions, 
respectively (Whitford, 1994). Ductal saliva has also been employed as a 
‘contemporary biomarker’ of fluoride exposure (Olympio et al., 2007; Wilson and 
Bawden, 1991; Zero et al., 1992). Concentrations of fluoride in the whole saliva are 
more variable and higher than those seen in ductal saliva. Exogenous fluoride 
contamination of whole saliva renders it unsuitable for estimation of plasma fluoride 
concentrations as a ‘contemporary biomarker’. (Whitford et al., 1999).  
 
1.1.2.2.3 Distribution in mineralized tissues 
Approximately 99% of the fluoride is found in the mineralized tissues of the body 
such as; bone, enamel, and dentin (Whitford, 1994). Fluoride concentration in bone 
is not uniform. The concentrations of fluoride in long bone are higher in the 
periosteal and endosteal regions. As compared to compact bone, cancellous bone 
has higher fluoride concentrations due to its greater surface area in contact with the 
surrounding extracellular fluid. Bone fluoride concentrations tend to increase with 
age due to continuous fluoride uptake throughout the life (Richards et al., 1994). 
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It is estimated that approximately 36% of the absorbed fluoride becomes 
associated with the bone, while the remainder is excreted. In children, the degree of 
retention is much higher (55%) (Villa et al., 2010) due to the rich blood supply and 
large surface area of the growing bones (Whitford, 1994). 
Fluoride concentrations in the dentin are similar to bone fluoride concentrations 
and increase with age. Dentin fluoride levels are higher close to the pulp and reduce 
progressively towards the dentino-enamel junction (Rao et al., 1995). Enamel 
fluoride concentrations are usually lower than the levels found in dentin. No 
correlation was found between the concentrations of fluoride in dentin and enamel 
(Vieira et al., 2004; Vieira et al., 2006). Concentration of fluoride in the dental 
enamel decreases with age, especially in areas where dental biofilm accumulates. 
The fluoride concentrations in the dental enamel reflect the level of fluoride exposure 
during amelogenesis (process of enamel formation) (Rao et al., 1995). A significant 
correlation between the severity of dental fluorosis and fluoride concentrations has 
been found only for the dentin. (Vieira et al., 2004; Vieira et al., 2006). 
 
1.1.2.3 Renal clearance 
The kidneys play a major role in fluoride removal from the body. Under normal 
conditions, approximately 60% of fluoride absorbed each day by healthy adults is 
excreted in urine. In children about 45% of the absorbed fluoride is excreted through 
urine (Villa et al., 2010). More fluoride is retained in children as compared to the 
adults may be due to the growing skeleton in the children and comparatively slow 
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bone remodeling in adults. Fluoride in the plasma and urine reflects a physiologic 
balance between fluoride intake and removal.  
The concentrations of fluoride in the glomerular filtrate and plasma are 
comparable. After entering the renal tubules, a variable amount of the ion is 
reabsorbed and returned to the systemic circulation (Whitford, 1996). Tubular 
reabsorption of fluoride and glomerular filtration rate are the principal determinants 
of the urinary fluoride excretion. Compared to the renal clearance of other halogens 
(~1-2 mL/min), fluoride has high renal clearance (35mL/min). However, individual 
variations in the renal clearance of fluoride are common (Whitford, 1994) and are 
attributed to the three major factors; differences in the glomerular filtrations rates 
(Spak et al., 1985), pH of urine (Jarnberg et al., 1983) and urinary flow rate 
(Ekstrand et al., 1982). 
The mechanism of renal tubular reabsorption of fluoride is also pH-dependent 
and occurs by diffusion as HF (Whitford et al., 1976). Hence, when the pH of the 
tubular fluid is relatively high, the proportion of fluoride as HF is lower while there is 
a higher proportion of fluoride as [F-]. Only a small amount of HF crosses the 
epithelium of the renal tubule to be reabsorbed and a high amount of fluoride is 
excreted in urine. Conversely, when the pH of the tubular fluid is lower, high 
amounts of HF cross the tubular epithelium into the interstitial fluid where the pH is 
relatively neutral which promote the dissociation of HF. Dissociated fluoride then 
diffuses into peritubular capillaries and is returned to the systemic circulation.  
 
 
9 
 
1.1.2.4 Fecal clearance 
Fecal fluoride represents less than 10% of the ingested fluoride. In other words, 
more than 90% of ingested fluoride is usually absorbed (Ekstrand et al., 1994). 
When diets containing high amounts of calcium are consumed, unabsorbed calcium 
forms complexes with fluoride in the stomach. The complexes of calcium and 
fluoride do not easily diffuse through the GI lining and thereby reduces the total 
amount of fluoride absorbed. (Whitford, 1994). 
 
1.1.2.5 Factors modifying metabolism 
1.1.2.5.1 Acid-base equilibrium 
Acid-base equilibrium plays an important role on the metabolism and tissue 
concentrations of fluoride. Factors that alter the acid-base equilibrium include diet 
composition (vegetarian diet increases urinary pH), altitude, drugs, metabolic and 
respiratory disorders. Acute respiratory acid-base disorders affect renal excretion of 
fluoride in the same manner as the metabolic disorders (Whitford, 1996). 
 
1.1.2.5.2 Renal impairments 
A direct relationship between renal impairment and enamel defects (such as 
enamel hypoplasia) was observed in humans (Al-Nowaiser et al., 2003; Farge et al., 
2006; Koch et al., 1999). In a study comparing children with renal disease to healthy 
children, the frequency of dental fluorosis was not significantly different between the 
two groups. However, children  with renal disease demonstrated more severe dental 
fluorosis than children without renal disease (Ibarra-Santana et al., 2007).  
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1.1.2.5.3 Altitude  
Rats raised in hypobaric chambers to stimulate high altitudes demonstrated 
increased enamel disturbances, regardless of the levels of ingested fluoride 
(Whitford, 1996). Alterations in acid-base balance, caused by hypobaric hypoxia due 
to high altitude of residence were responsible for decreased urinary fluoride 
clearance. This decrease in urinary fluoride clearance resulted in greater retention of 
fluoride (Whitford, 1997). A significantly higher prevalence of fluorosis has been 
observed in Tanzanian communities at a high altitude (1,463 m), in contrast with a 
low altitude area (100m), with similar food habits and low levels of fluoride in the 
drinking water (Yoder et al., 1998). The severity of enamel disturbances at the high 
altitude area was not consistent with the fluoride concentration in drinking water. 
Such a finding suggested that altitude, along with other factors, may contribute to the 
severity of enamel disturbances. Studies conducted in other high altitude locations 
around the world confirmed that physiological changes associated with residence at 
high altitude are able to exacerbate the effects of fluoride on mineralized tissues 
(Akosu and Zoakah, 2008; Martinez-Mier et al., 2004; Pontigo-Loyola et al., 2008).  
 
1.1.2.5.4 Physical activity 
Prolonged physical activity reduces the pH gradient across cell membranes, 
especially skeletal muscle cells, which promote the diffusion of fluoride from the 
extracellular to the intracellular fluid. Physical activity-mediated catecholamines 
secretion can lead to renal vasoconstriction leading to decreased renal fluoride 
clearance. Depending on the balance of several factors, exercise could be 
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associated with either decrease or increased circulating fluoride levels (Whitford, 
1996). Although physical activity may alter the pattern of fluoride excretion, the 
impact on the development of dental fluorosis seems negligible. 
 
1.1.2.5.5 Circadian rhythm  
Daily variations are observed in levels of calcium and phosphorus which are 
involved in bone remodeling (the process involving a balance between deposition 
and resorption of bone) under the influence by mineral homeostatic hormones. 
Fluoride, similar to calcium and phosphorous, is primarily stored in the skeleton and 
therefore, it was hypothesized that plasma fluoride levels would exhibit circadian 
rhythm too (Talmage et al., 1975). Such rhythmicity was verified in dogs, with a 
mean peak fluoride concentration around 9 AM, followed by a decrease around 9 
PM (Whitford, 1996). 
Whitford et al demonstrated a rhythmicity of fluoride concentrations in human 
plasma, with mean peak (0.55 µmol/L) at 11 AM and the lowest concentrations 
occurring between 5 and 8 PM (Whitford et al., 2008). Plasma fluoride 
concentrations were positively correlated with urinary fluoride excretion rates and 
with parathyroid hormone (PTH) levels, suggesting that both the renal system and 
mineral homeostatic hormone (PTH) might be involved in the rhythmicity of plasma 
fluoride.  
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1.1.2.5.6 Nutrition 
A correlation between malnutrition and prevalence of dental fluorosis prevalence 
has been suggested in the past; however, the evidence for such a relationship is 
controversial. In a study with Tanzanian children, Yoder et al suggested a direct 
relationship between malnutrition and dental fluorosis (Yoder et al., 1998) whereas 
another study demonstrated that dental fluorosis is independent of nutritional status 
(Buzalaf and Whitford, 2011). Nutritional status is commonly assessed by the height-
for-age and weight-for-age indices as per the recommendations by the World Health 
Organization (WHO). It is hypothesized that a malnourished child may absorb 
fluoride more quickly due to the inexistence of ions to form complexes in an empty 
stomach. On the other hand, a malnourished child may have low fluoride deposition 
due to slower bone growth. 
The prevalence of dental fluorosis and severity of dental defects were compared 
between the children fed vegetarian or non-vegetarian diet (Awadia et al., 1999). In 
the vegetarian group, the enamel fluorosis severity and prevalence were 21% and 
67% whereas; in non-vegetarian group it was 35% and 95% respectively. 
Additionally, the calculated risk for developing enamel fluorosis was 7 time higher in 
non-vegetarian diet fed children as compared to the vegetarian diet fed children. 
Tamarind extracts have been used to promote urinary fluoride excretion by 
increasing urinary pH in school children (Khandare et al., 2004). Tamarind paste 
contains 8.4-12.4% tartaric acid, which is not metabolized in the body and eventually 
is excreted through urine. Tartaric acid reduces the pH of urine which forces fluoride 
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to remain in a dissociated form as [F-] and hence fluoride cannot be reabsorbed (as 
HF) in the kidneys. This ultimately leads to fluoride wasting.  
High dietary concentrations of certain cations, especially calcium, can reduce the 
extent of fluoride absorption (Vieira et al., 2004; Vieira et al., 2006). A study 
reviewed by Buzalaf et al, conducted in the province of Jaingxi, China, where the 
prevalence of dental fluorosis was reported to be above 50%, the consumption of 
milk was a critical factor influencing the incidence of dental fluorosis in children. The 
incidence of dental fluorosis among the children consuming milk was lower (7.2%) 
as compared to the children not consuming milk (37.5%).  (Buzalaf and Whitford, 
2011). In India, where approximately 62 million people have dental fluorosis, studies 
have been conducted to identify increased risk of dental fluorosis due to dietary 
components, other than fluoride (Bhargavi et al., 2004). Low calcium concentrations 
in the drinking water and prevalence of dental fluorosis are inversely related. 
Therefore, calcium supplementation in areas with endemic fluorosis will minimize the 
absorption of fluoride through water and will avoid excessive incorporation of fluoride 
in the mineralized tissues (Khandare et al., 2005). 
 
1.1.2.5.7 Genetic influences 
A study conducted in three distinct areas of Tanzania, which differed in water 
fluoride concentrations and altitude, demonstrated that at two out of three areas with 
severe fluorosis, several children had very little evidence of enamel disturbances 
(Yoder et al., 1998). Urinary fluoride values and fluoride values in the food were 
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similar between those two groups. Differences between two homogeneous tribes 
raised the possibility of genetic influence on fluorosis prevalence.  
Genetic predisposition to dental fluorosis was demonstrated in 12 strains of mice. 
Other confounding variables such as age, sex, food and housing were controlled. 
(Everett et al., 2002). The 12 inbred strains of mice showed variable susceptibilities 
to dental fluorosis. The A/J strain demonstrated highly susceptibility to dental 
fluorosis; whereas, 129P3/J mouse strain demonstrated minimal dental fluorosis. 
The onset of dental fluorosis in the A/J strain was rapid with highest severity 
amongst the tested strains. Two strains; A/J and 129P3/J, demonstrated variable 
responses on the bone after fluoride exposure (Mousny et al., 2006). It was 
hypothesized that the different susceptibility to dental fluorosis between these two 2 
strains was due to differences in fluoride metabolism (the resistant strain would 
excrete more fluoride which in turn would lead to decreased susceptibility to dental 
fluorosis). A metabolic study to test this hypothesis revealed an interesting finding. 
The resistant strain (129P3/J) excreted a significantly lower amount of fluoride in 
urine than the susceptible strain (A/J) resulting in higher plasma and bone fluoride 
concentrations. The fluoride, however, did not affect the amelogenesis in the 
129P3/J strain (Carvalho et al., 2009). In mouse, the quantitative trait loci associated 
with dental fluorosis were detected on chromosomes 2 and 11 (Everett et al., 2009). 
Histological examination of maturing enamel showed that fluoride treatment resulted 
in accumulation of amelogenins in the maturing enamel of A/J mice, but not of 
129P3/J mice. All these studies indicate that the mechanism of fluorosis can only be 
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partly explained with genetics. The differences in fluorosis susceptibility may involve 
physiological, biochemical, and molecular differences in theses mouse strains.  
 
1.1.3 Toxicity 
Systemic toxicity of fluoride can occur following fluoride exposure through dermal 
or parenteral route (Augenstein et al., 1991; Mullins et al., 1998; Yolken et al., 1976). 
Toxicity of fluoride is due to electrolyte disturbances such as: hypocalcemia, 
hypomagnesemia, and hyperkalemia (Greco et al., 1988; Kao et al., 1999; Stremski 
et al., 1992). In 2001, the Toxic Exposure Surveillance System of American 
Association of Poison control Centers reported about 1200 HF exposure incidents 
(Litovitz et al., 2002). Severity of the exposure depends mostly on the concentration 
of the HF and the total surface area of body affected or exposed. Often, the HF 
exposure leads to mild to moderate dermal or ocular injuries, but exposure to very 
high doses of HF leads to life-threatening complications (Kao et al., 1999). Systemic 
exposure of high amounts of fluoride as HF leads to chelation of plasma calcium 
which leads to severe hypocalcemia which can be fatal (Mullett et al., 1987). 
Fluoride readily forms complexes with calcium and magnesium ions; hence antacids 
containing calcium or magnesium cations are routinely administered to avoid toxic 
effects of fluoride. Although oral antacids containing calcium and magnesium salts 
are effective for gastric decontamination after systemic HF exposure, they do not 
alter survival time after toxic dose of HF (Heard and Delgado, 2003). 
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1.1.4 Fluorides in dentistry 
The fluoride’s effect on prevention of dental caries was observed in the early 
1800s. Fluoride is naturally present in the surface drinking water in variable amount. 
Governmental agencies around the world have started programs to control the 
amount of fluoride in the drinking water depending on the average temperature and 
altitude of the area. Although controversial, the effectiveness of such programs have 
been established through the observations that water fluoridation programs led to a 
decline in the prevalence of dental caries. Billions of individuals in approximately 40 
countries are exposed to fluoride from adjusted fluoridated water supplies (Browne 
et al., 2005; Pizzo et al., 2007). In the US, according to the Center for Disease 
Control 2008 water fluoridation statistics, approximately two hundred million people 
receives fluoridated water. In other words, F reaches more than 70% of the US 
population through public water supply (Sampaio and Levy, 2011). Since the initial 
findings of the effectiveness of fluoride to prevent on caries, intensive research has 
been conducted to determine the benefits, safety, and the cost-effectiveness of 
fluoride delivery modalities other than water. Fluoridation of milk, salt, dietary 
supplements was undertaken as an alternative to augment fluoride supplementation 
to children and reduce caries incidence (Sampaio and Levy, 2011). Fluoride 
containing solutions, gels, foams, varnishes, rinses, and dentifrices can be applied 
topically to render teeth resistant to caries attack (Pessan et al., 2011).  
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1.1.4.1 Fluoride’s action on tooth enamel 
Dental enamel is primarily composed of minerals of calcium and phosphate 
commonly termed as hydroxyapatite (HAP) (McCann, 1953). The HAP crystals form 
a closely packed lattice structure. Fluoride can replace hydroxyl (OH), carbonate 
(CO32-) and phosphate (PO43-) ions in HAP lattice to form fluorapatite (FAP). FAP 
renders enamel hard and resistant to decay and acid attack. 
Ca10(PO4)6(OH)2 + 2F-  Ca10(PO4)6F2 +2OH- 
  (Hydroxyapatite)              (Fluorapatite) 
Calcium present on the outer surface of the enamel complexes with fluoride 
to form fluorite (CaF2). Fluorite is resistant to acid dissolution and hence renders the 
outer surface of enamel resistant to demineralization after bacterial acid attack. 
Fluorite also acts as a source for fluoride ions. Reversibly bound fluoride to the 
calcium can be released in saliva to raise salivary fluoride concentration. Fluoride 
also diffuses to the underlying enamel layers where it replaces the OH, CO32- or 
PO43- ions and forms FAP. 
The rate of formation of FAP is dependent on the pH of saliva and 
concentration of fluoride in the saliva (McCann, 1953). Apart from the role of fluoride 
in reducing demineralization by formation of FAP, fluoride also has an antimicrobial 
effect (Marquis, 1995; Yoshihara et al., 2001). Fluoride slows down plaque 
metabolism by inhibiting glycolysis. Reduced metabolism decreases reproduction in 
bacteria which reduces the bacterial count and acid production. To summarize: 
• Fluoride forms FAP which is acid-resistant and renders the dental enamel 
resistant to demineralization. 
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• Fluoride promotes remineralization of demineralized tooth enamel by 
precipitation of fluorapatite from saliva 
• Fluoride inhibits bacterial growth in the plaque and prevents acid attack on 
the teeth 
 
1.1.4.2 Enamel fluorosis 
Enamel fluorosis is defined by porous and discolored enamel with increased 
protein content and decreased mineral content (Robinson et al., 2004; Wright et al., 
1996). Matsuo et al demonstrated that fluoride exposure of ameloblasts leads to G 
protein-mediated disturbance in intracellular transport (Matsuo et al., 1996).  
Fluoride treatment of the ameloblasts altered the composition and rate of synthesis 
of enamel proteins (Lyaruu et al., 1986). Bronckers et al demonstrated that fluoride 
treatment did not alter amelogenin synthesis by the ameloblasts however it altered 
the secretion of amelogenin (Bronckers et al., 1984). Demonstration of increased 
number of large vacuoles in the cytoplasm of the secretory ameloblasts after fluoride 
treatment provides further evidence of fluoride-mediated decrease in the vesicular 
fusion and secretion of the proteins (Mornstad and Hammarstrom, 1978). Similarly in 
rat ameloblasts, fluoride treatment led to an increased accumulation of secretory 
vesicles suggestive of derangement in protein trafficking due to fluoride (Matsuo et 
al., 1996). Guanosine triphosphate binding proteins are important for vesicular 
transport (Hall, 1987). On the golgi bodies the secretory proteins vesicles receives 
their coat protein complex. This process is regulated by the guanosine triphosphate 
binding proteins (Finazzi et al., 1994). In ameloblasts too, the guanosine 
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triphosphate binding proteins (such as heterotrimentric G proteins) regulates vesicle 
formation in the golgi complex (Leyte et al., 1992). 
 
1.1.5 Interactions on bone 
1.1.5.1 Bone remodeling, osteoblasts and osteoclasts 
Bone remodeling is a process that involves a balance between osteoclast and 
osteoblast activity. Osteoblasts increase bone mass and osteoclasts resorb bone. 
This fine balance between the osteoclasts and osteoblasts activity is essential to 
maintain bone homeostasis. Fluoride actions on bone are influenced by the 
concentration of fluoride. Physiological concentrations of fluoride promote osteoblast 
proliferation and increased matric production. Fluoride concentrations higher than 
physiological concentrations suppresses proliferation by inducing apoptosis of 
differentiated osteoblast (Allolio and Lehmann, 1999). The effects of fluoride on the 
osteoclasts are contradictory. Rodent bone marrow osteoclast precursor cells 
demonstrated increased tartrate-resistant acid phosphatase activity after fluoride 
treatment suggestive of increased fluoride-mediated osteoclast number and activity 
(Debinski and Nowicka, 2004; Yan et al., 2007). Contrary to this finding, another 
study demonstrated a fluoride-mediated reduction in osteoclast number and bone 
resorption (Okuda et al., 1990). The underlying molecular mechanism for fluoride’s 
action on osteoclasts is not clearly understood.  
Multinucleated osteoclasts are derived from hematopoietic progenitor cells. 
Osteoclasts are terminally differentiated cells and are responsible for bone 
resorption. Osteoclasts are generated following mechanical response and the 
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number of differentiated osteoclast are very few long the bone surfaces. (Tanaka et 
al., 2006; Yavropoulou and Yovos, 2008). Osteoclasts can be induced from bone 
marrow macrophages (BMM) using two cytokines: receptor activator of nuclear 
factor-κB  ligand (RANKL) and macrophage colony-stimulating factor (M-CSF) 
(Boyle et al., 2003). Osteoclast precursors fuse together to form multinucleated, 
terminally differentiated osteoclast. NFATc1 upregulates DC-STAMP to stimulate 
osteoclast precursor fusion (Kim et al., 2008) which triggers formation of functional 
osteoclast. Functional, multinucleated osteoclasts attaches to the bone and forms a 
tight seal underneath which hydrogen ions are pumped to create an acidic 
environment for bone resorption (Song et al., 2009). Acidic environment help 
osteoclasts to degrade the inorganic bone matrix. Osteoclasts also secrete matrix 
metalloproteinase (MMP9) which is involved in the degradation of organic matrix 
(Kim et al., 2008; Song et al., 2009). 
Fluoride effect was studied on intracellular second messengers (calcium 
concentrations) in osteoblast-like cell line (Mertz, 1981). Fluoride increased 
intracellular calcium transiently independent of external calcium and the magnitude 
is dependent on culture dentistry (Kawase et al., 1988). Fluoride also increased 
cytosolic free calcium concentrations in hepatocytes (Blackmore and Exton, 1986), 
platelets (Poll et al., 1986) and neutrophils (Strnad and Wong, 1985), and thereby 
induced differentiated functions. It is interesting to know that, PTH and 1,25 
hydroxyvitamin D3 (1,25 (OH)2D3) are also known to induce intracellular calcium 
mobilization and alter ALP activity (Boland et al., 1986; Yamaguchi et al., 1987). 
Farley et al reported that micromolar concentration of sodium fluoride enhances 
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DNA synthesis and ALP activity in osteoblasts (Farley et al., 1983). Fluoride also 
demonstrated an increase in patients with osteoporosis (Riggs et al., 1980).  
 Fluoride action induced cell proliferation in bone cells at a concentration of 10 
µM. This concentration is comparable to the serum fluoride concentration in humans 
(Farley et al., 1983). Mitogenic effects of fluoride on bone cells from other species 
including human was confirmed by various researches (Burgener et al., 1995; Hall, 
1987; Kassem et al., 1993; Khokher and Dandona, 1990; Modrowski et al., 1992; 
Reed et al., 1993; Wergedal et al., 1988). 
There is now compelling evidence that fluoride at mitogenic (µM) concenrations 
stimulates mature osteoblast activities such as alkaline phosphatase expression 
(Khokher and Dandona, 1990; Wergedal et al., 1988), collagen synthesis (Kassem 
et al., 1993; Modrowski et al., 1992) and osteocalcin production (Kassem et al., 
1994) in monolayer cultures. Fluoride at mitogenic concentrations also stimulated 
calcium uptake (Farley et al., 1983; Zerwekh et al., 1990) and sodium-dependent 
phosphate transport (Selz et al., 1991) in osteoblasts. Therefore, it is widely 
accepted that at low doses, fluoride stimulates osteoblast proliferation leading to 
increased bone formation. 
 
1.1.5.2 Characteristics of fluoride’s actions and hypotheses 
Mitogenic action of fluoride on the cells is seen at very low doses (µM). In the 
osteoblasts, the mitogenic actions of fluoride are reproducibly seen in an in vitro 
environment (Farley et al., 1983; Wergedal et al., 1988). The mitogenic actions of 
fluoride on the bone cells are typically evident in present of growth factors (Farley et 
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al., 1988; Reed et al., 1993). Phosphate concentration in the media used for in vitro 
experiments often influence the fluoride sensitivity of the cells to induce mitogenic 
changes (Farley et al., 1988). Fluoride acts on various cell types, however the 
effects of fluoride on the osteoblast precursor cells are more pronounced (Bellows et 
al., 1990; Farley et al., 1990). Fluoride’s mitogenic actions on the osteoblasts are 
commonly mediated through increased activation of various signaling proteins, 
including mitogen-activated protein kinase (MAPK) (Lau et al., 1989; Thomas et al., 
1996; Wu et al., 1997) 
Fluoride is interestingly known to skew the balance between bone formation and 
resorption towards the bone formation. This overall shift results in increased bone 
deposition resulting in overall increase in bone mass. Several laboratories around 
the world are trying to uncover the mechanistic aspect of fluoride’s action on cell 
types involved in biomineralization especially osteoblast cells. The understanding 
the exact mechanism of fluoride’s action on bone formative cell, osteoblast, will 
further our understanding of the pathophysiology of degenerative bone diseases and 
thereby help development of efficient therapeutic strategies. Based on some 
literature findings, researchers have proposed two possible mechanism of fluoride’s 
action on bone cells. These two hypotheses are presented below.   
 
1.1.5.2.1 Tyrosine phosphate hypothesis 
High acid phosphatase activity on phosphotyrosine was noted in osteoblast-like 
cells after fluoride treatment. The acid phosphatase activity on phosphoserine and 
phosphothreonine after fluoride was relatively unaffected (Lau et al., 1989; Lau and 
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Baylink, 1998). These findings suggest that the effects of fluoride are mediated 
through the tyrosine phosphate pathway. Proteins harvested from chicken calvarial 
cells, which were exposed to fluoride, demonstrated increased amount of 
phosphorylated plasma proteins (Lau et al., 1989). We know that the effects of most 
growth factors are mediated through tyrosine kinase receptors present on the cell 
surface. Fluoride sensitizes the cells to readily respond to mitogenic actions of 
growth factors (Lau et al., 1987). These observations led to the formulation of this 
first hypothesis for the mechanism of fluoride’s action.  
Cells derived from human osteosarcoma demonstrated an increase in amount of 
tyrosyl phosphorylated proteins in response to low doses of fluoride (~50-200µM). 
Increasing the fluoride concentration further increased the amount of phosphorylated 
proteins such as ERK 1/2 (Thomas et al., 1996). Similar response to fluoride was 
seen in the cells isolated from human mandibular bone chips (Thomas et al., 
1996). The phosphorylation events were observed after a relatively long time which 
might be suggestive of a fluoride-mediated inhibition of phosphotyrosyl 
phosphatases. Although various literature findings support this hypothesis further 
studies are required to conclusively prove this hypothesis.  
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Figure 1.1: Fluoride action hypotheses 
 
Fluoride inhibits the tyrosine phosphatase leading to increased phosphorylation 
of signaling proteins such as ERK 1/2 triggering proliferation (A) (Lau et al., 1989; 
Thomas et al., 1996). Fluoride along with other multivalent ions stimulates GDP 
to convert into GTP which is required for the activation of G proteins which in turn 
activates and phosphorylated signaling proteins including ERK 1/2 which are 
required for cell proliferation (B) (Caverzasio et al., 1996; Caverzasio et al., 
1997).  
 
1.1.5.2.2 G protein hypothesis 
In myocytes, fluoride as fluoroalumino complexes can activate ERK2 kinase, an 
enzyme involved in cell differentiation and proliferation (Anderson et al., 1991). 
 Fluoride, in presence of multivalent ions such as aluminum, induced cell 
proliferation in osteoblast live cells, MC3T3-E1 (Caverzasio et al., 1996).  
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Heterotrimeric G proteins (Gi and Gq), triggers cell proliferation is widely 
accepted. However, the mechanism underlying this triggering of cell proliferation is 
not clear (Post and Brown, 1996; van Biesen et al., 1996). The involvement of Ras 
pathways leading to ERK phosphorylation by G protein has been studied in the past 
(Post and Brown, 1996) along with the involvement of the Grb2 and Sos (Post and 
Brown, 1996; van Biesen et al., 1996). Similar to the first hypothesis, this second 
hypothesis needs additional experimental evidence is required to understand the 
fluoride’s mode of action (van Biesen et al., 1996).  
 
1.1.5.5 Skeletal fluorosis 
Fluoride is predominantly stored in the mineralized tissues of the body such as 
enamel, dentin, and bones. In the bone fluoride demonstrate a biphasic actions 
(Collier, 1980). Fluoride, at low doses, provides hardness to the bone and renders 
enamel less susceptible to acid dissolution (Parnell et al., 2009). However, excess 
systemic exposure to fluoride can lead to skeletal and dental fluorosis. Skeletal 
fluorosis (SF) is a bone condition characterized by spectrum of bone changes 
ranging from osteoporosis to osteosclerosis. SF is clinically characterized by 
stiffness and rigidity of bone, restricted joint movements, bending deformities of 
spine and rotational deformities of long bones and calcification of ligaments and 
tendons (Ismail and Hasson, 2008). Fluoride reduces mineral solubility in the bone 
thereby affecting calcium metabolism in the body (Messer et al., 1973). 
Bone histomorphometric studies demonstrated that fluoride exposure lead to 
increased bone mass. Additionally, the number of functional osteoblasts was higher 
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after fluoride exposure. Fluoride-mediated proliferation of bone forming cells is 
indicative of anabolic effect of fluoride on the bone. It was previously speculated that 
fluoride renders bone hard and resistant to resorption. The increase in bone mass 
after fluoride exposure is attributed to excessive bone formation rather than 
decreased bone resorption (Briancon and Meunier, 1981; Riggs et al., 1980). 
Although fluoride exposure increased bone mass and bone mineral density, it did not 
reduce the incidence of fractures undermining the effectiveness of fluoride treatment 
(Kleerekoper et al., 1991; Pak et al., 1994; Riggs et al., 1990; Riggs et al., 1994). 
Thus effectiveness of fluoride as a therapeutic agent can be enhanced if the benefit-
to-risk profile of fluoride is improved. This improvement in benefit-to-risk profile can 
be achieved by understanding the mechanism of fluoride’s action.  
SF has been extensively studied in fluoride endemic areas (Fig. 1.2) of the world. 
Most of the SF related data comes from Brazil, China and India where levels of 
fluoride in drinking water are higher than optimal, 1.5 parts per million (ppm). SF 
features can be broadly categorized as: generalized osteosclerosis and fluorotoxic 
metabolic bone disease (FMBD). Both these clinical pictures are based on the 
amount of dietary intake of calcium. Children demonstrating low intake of calcium, 
show FMBD with significant serum biochemical abnormalities. Radiographs of 
patients, living in an area of China where fluoride in drinking water was >5ppm, were 
studied for SF. Radiographs of the patients were screened for features such as, 
osteosclerosis (increased bone density with cortical thickening), osteoporosis 
(decreased bone density, thinned cortices and decreased number of trabaculae 
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without bone deformity), osteomalacia (osteoporosis with bone deformity), 
intermittent growth lines and diaphyseal widening and soft tissue calcification. 
 
Figure 1.2: Ground water fluoride concentration around the world. 
  
Reprinted with permission from Amini M, Mueller K, Abbaspour KC, Rosenberg T, 
Afyuni M, Møller KN, Sarr M, Johnson CA., Statistical modeling of global geogenic 
fluoride contamination in groundwaters., Environ Sci Technol. 2008 May 
15;42(10):3662-8. Copyright 2008 American Chemical society. 
 
It was observed that approximately half of the SF patients demonstrated 
osteosclerosis and rest demonstrated osteoporosis or osteomalacia (Wang et al., 
1994). Also, intermittent growth lines, diaphyseal widening and calcification of 
tendons and ligaments were seen as additional overlapping features. It was 
concluded that radiographic features of SF have a wide spectrum of radiographic 
characteristics. In another study undertaken in fluoride endemic parts of India with 
>5ppm fluoride concentration in drinking water, variable radiographic features were 
reported in children affected with skeletal fluorosis.  
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Clinical findings of SF (Fig. 1.3) includes stiffness and rigidity of spine and joints, 
flexional deformities of bones, rotational deformities of legs, neurological 
complications, arthralgia, pseudo-hyperparathyroidism and restricted movements 
(Teotia et al., 1998). Teotia et al also found that pseudo-hyperparathyroidism was a 
common finding in patients with SF (Teotia and Teotia, 1973). Another study 
undertaken in Turkish population indicated that PTH was elevated in SF patients 
along with a decrease in serum calcium (Koroglu et al., 2011). Harinarayan et al 
reported that in FMBD patients demonstrated serum phosphorus and 1,25(OH)2D3 
values comparable to the control group. Serum alkaline phosphatase (ALP) and 
PTH mid-molecule (PTH-MM) levels were higher (Harinarayan et al., 2006). 
Additionally, serum calcium, creatinine clearance and phosphorus excretion index 
were decreased. It is interesting to note that although, the patients in this study 
demonstrated similar clinical picture, they were exposed to variable amount of 
fluoride through drinking water, ranging from 0.23-14ppm (Harinarayan et al., 2006). 
Collectively, the findings can be summarized as:  
• SF demonstrates variable radiographic and clinical picture  
• Persistent elevation of PTH in fluoride endemic areas 
• Pseudo-hyperparathyroidism is a common finding in fluoride endemic area 
• Patients demonstrating similar clinical and radiographic picture were exposed 
to variable fluoride levels  
 Figure 1.3: Clinical and radiographic features of skeletal fluorosis
Reprinted with permission from
changes in children with fluorosis.
1980 Radiological Society of North 
Whitford GM., Skeletal fluorosis from instant t
May;23(5):759-69. Copyright 2008 American Society of Bone and Mineral Research.
  
 1.1.5.6 Fluoride and parathyroid h
  
Yan et al in 2007 (Yan et al., 2007
on bone homeostasis in two strains of mice: C3H/HeJ
These mice are extensively studied for their bone and bone cell properties. C3H has 
high bone mass, peak bone density, serum alkaline phosphatase activity and lower 
bone resorption rate as compared to B6 
Linkhart et al., 1999; Turner et al., 2000
female mice were exposed to fluoride
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osteoclast biomarkers, in situ osteoclast numbers, osteoclast potential and 
hematopoietic colony forming cell assay, micro-computed tomography (µCT) 
analysis and biomechanical properties of bone were studied. After 3 weeks of 
fluoride exposure, C3H and B6 mice demonstrated variable effects. B6 mice began 
with higher bone fluoride and accumulated more fluoride in bone as compared to 
C3H. Anabolic actions of fluoride were favored in B6, including increase in serum 
ALP activity, increase in mineralized bone volume and trabacular thickness. 
However, in C3H, fluoride favored osteoclastogenesis demonstrated by an increase 
in bone marrow osteoclast potential and increase in osteoclast number along with an 
increase in serum osteoclast biomarkers including intact PTH (iPTH), sRANKL, 
TRAP5b and decrease in OPG. Similar results were found when the same strains of 
mice were exposed to long term fluoride exposure (Yan et al., 2011). Interesting 
finding of both the studies was elevated iPTH which was consistent with findings in 
fluoride endemic areas (Harinarayan et al., 2006; Teotia et al., 1998; Teotia and 
Teotia, 1973). 
 
1.2 Parathyroid hormone (PTH) 
1.2.1 Mineral homeostasis and bone-intestine-parathyroid-kidney (BPK) 
axis 
Calcium is required in the body for proper maintenance of neuromuscular 
function and hard tissue mineralization. The levels of the calcium in the body are 
tightly regulated. Parathyroid gland Chief cells are sensitive to the changes in the 
level of ionized calcium in the body which is maintained at 1.2-1.3mM. Even a slight 
31 
 
change in the ionized calcium levels triggers secretion of PTH by the Chief cells. 
PTH actions are required to restore the normocalcemic state in the body. PTH 
normalizes plasma ionic calcium levels by three defined actions:  
1. PTH mediates production of osteoclast in the bone which resorbs bone and 
release calcium in the blood 
2. PTH acts on kidney to induce calcium reabsorption 
3. PTH has an indirect action on intestine. In the kidneys PTH signals to 
increase 1αhydroxylase production which promotes calcium absorption in the 
intestine. 
FGF23 and 1,25(OH)2D3 are involved in feedback regulation to check levels of 
PTH. The interaction of these three hormones is required for the calcium 
homeostasis. The cross-talk between these three tissues to achieve calcium 
homeostasis has been traditionally referred as bone-parathyroid-kidney (BPK) axis. 
However, the indirect involvement of intestine in the absorption of calcium is crucial 
for successful calcium regulation. Hence we now refer this control mechanism for 
calcium homeostasis as the BPK as bone-intestine-parathyroid-kidney (BIPK) axis 
(Fig. 1.4) 
Blood calcium levels are constantly monitored by a membrane bound G protein-
coupled receptor, calcium sensing regulator (CASR), present on the parathyroid 
gland chief cells, bone and kidneys. Chief cells of parathyroid gland produce and 
store PTH in vesicles for quick release in case of demand. PTH acts on kidney 
through its receptor PTH1R to modulate production of 1α hydroxylase which produce 
1,25(OH)2D3 to help calcium absorption in the intestine. Decreased 1,25(OH)2D3 
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production is sensed by vitamin D receptor (VDR) on parathyroid gland which 
signals production of PTH.  
Action of PTH on kidneys leads to calcium reabsorption and phosphorus 
excretion through Solute carrier family 34 member 1 (SLC34A1), Solute carrier 
family 9 member 3 regulator 1 (SLC9A3R1), PDZ domain containing 1 (PDZK1), and 
chloride channel 5 (CLCN5). PTH production is also influenced by FGF23, a 
hormone produced by bone osteocytes and is responsible for phosphate regulation. 
FGF23 acts on parathyroid gland through its receptor couple, αKLOTHO and 
FGF1Rc, to suppress PTH production. FGF23 also acts on kidneys via its receptor 
couple to induce phosphorus excretion. Intestine plays a vital role in maintaining 
mineral absorption and hence mineral homeostasis is influenced by interaction of 
bone, parathyroid, intestine and kidneys. Therefore, it will be appropriate to call BPK 
axis as bone-intestine-parathyroid-kidney (BIPK) axis.  
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Figure 1.4: Bone-Parathyroid-Kidney (BPK) axis 
(Adapted from Donate-Correa et al., 2012; Landry et al., 2011; Razzaque, 2009; 
Strom and Juppner, 2008) 
 
1.2.2 PTH and PTHLH 
Full length PTH polypeptide has 84 amino acid with 9.4kDa molecular mass. 
PTH is secreted by the Chief cells of the parathyroid gland. Developmentally, 
parathyroid tissues can get entrapped in the thymus in which case the thymic tissue 
can be a source of PTH (Gunther et al., 2000). Evolutionarily, two primitive forms of 
PTH are seen in fishes which even lack an identifiable parathyroid gland tissue. 
(Gensure et al., 2004; Hogan et al., 2005). In spite of the sequence similarity, the 
functional potency of these primitive forms of PTH is lower than human PTH. 
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Therefore, similar to human PTH, these primitive forms of PTH might be involved in 
the development of skeletal and neural systems in these fishes (Guerreiro et al., 
2007).  
The sequence of parathyroid hormone like hormone (PTHLH) in the amino 
terminal region (1-34) is homologous to PTH. PTHLH is required for endochondral 
bone formation and also mediates hypercalcemia in malignancy (Broadus et al., 
1988; Strewler et al., 1987; Suva et al., 1987). PTHLH is necessary for development 
of teeth and mammary glands due to its involvement in epithelial-mesenchymal 
interactions (Gensure et al., 2005). Due to the sequence similarity between PTH and 
PTHLH, both these may have a common ancestral origin (Abbink and Flik, 2007).  
 
1.2.2.1 Synthesis and secretion of PTH 
In humans, the PTH gene is present on the short arm of chromosome 11 
(11p15.3-p15.1). A 25 amino acid presequence and a 6 amino acid prosequence is 
present in the precursor PTH molecule along with an 84 amino acid full length 
mature PTH sequence (Usdin et al., 2008). The presequence is required for the 
shuttling of the precursor PTH polypeptide across the endoplasmic reticulum (ER). 
The prosequence function is not clearly defined yet; however, the involvement 
prosequence in precursor PTH polypeptide folding has been postulated. (Wiren et 
al., 1989). After the movement of precursor PTH polypeptide through ER and 
subsequent folding events, mature PTH is packed into secretory vesicles. The 
mature PTH is then secreted in response to hypocalcaemia after vesicle fusion and 
exocytosis. PTH in the vesicle can have an alternative fate. In case of 
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hypercalcemia, calcium-sensitive proteases cleave PTH inside the secretory 
vesicles leading to the production of small PTH fragments which are devoid of 
classical PTH response. (Habener et al., 1975). PTH can be removed from the 
circulation after secretion through its cleavage in the kidneys and the liver (D'Amour, 
2006). Peripheral clearance of PTH by cleavage is required for abolishing the 
prolonged activity of PTH in the body. Peripheral clearance ensures that the PTH 
response is transient. The amino- and carboxyl-terminal fragments, generated after 
cleavage, may have distinct biologic roles (Murray et al., 2005). 
 
1.2.2.2 Regulation of PTH secretion  
1.2.2.2.1 Extracellular calcium-mediated regulation 
The primary function of the parathyroid gland Chief cells is to secrete PTH, a 
calcitropic hormone. Calcium sensing receptors (CASR) present on the Chief cells of 
parathyroid gland senses ionized calcium in the blood. Based on the blood ionized 
calcium levels, Chief cells modify PTH secretion. Increased ionized calcium levels 
lead to decreased PTH secretion, decreased ionized calcium levels increases PTH 
secretion. The response of the parathyroid gland chief cells to blood ionized calcium 
level is steep sigmoidal. Minor fluctuations in the blood ionized calcium levels can 
trigger appreciable changes in PTH secretion by the chief cells (Potts, 2005).  
Blood ionized calcium levels influences PTH secretion by the parathyroid Chief 
cells. Decrease in the blood ionized calcium levels increases parathyroid chief cell 
number (Proliferation) and thereby increase the expression of PTH. Increase in the 
levels of ionized calcium in the blood can reduce PTH secretion by two underlying 
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mechanisms. When there is an increase in the blood ionized calcium levels the 
proteases in the PTH vesicles are activated which then cleaves the PTH and 
generates functionally inactive small size PTH fragments. Similarly, when there is an 
increase in the blood ionized calcium levels it leads to the inhibition of PTH vesicle 
fusion with the parathyroid Chief cell membrane leading to a decrease in PTH 
secretion.  (Potts, 2005). The sensitivity of parathyroid Chief cells is achieved by a 
unique calcium sensing receptors, CASRs, present in the cell membrane. CASR 
have high affinity for ionized calcium. CASR dimer can bind to ionized calcium (at 
mM concentration) which leads to the receptor (CASR) activation (Ward et al., 
1998).  
The essential role of the CASR in humans was witnessed in loss-of-function 
mutations in the CASR gene (Brown and MacLeod, 2001). Heterozygous mutations 
of CASR results in familial hypocalciuric hypercalcemia (FHH), which clinically 
demonstrate increased circulatory levels of PTH along with hypercalcemia. FHH 
patients also demonstrate reduced number of CASR on the parathyroid Chief cells. 
Hence, due to absence of functional CASRs on the parathyroid Chief cells, calcium 
supplementation does not reduce PTH levels in the individuals with FHH. 
Homozygous mutations of CASR lead to neonatal severe primary 
hyperparathyroidism (NSHPT) which is characterized by abnormally high PTH levels 
and severe hypercalcemia (Grant et al., 2012). Heterozygous and homozygous 
mutation of Casr in mice demonstrates comparable clinical picture as seen in 
heterozygous and homozygous CASR mutations in humans respectively. (Liu et al., 
2011).  
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Alternative form of CASR is expressed in the bone, cartilage, kidneys, intestine 
and thyroid gland parafollicular cells. (Brown and MacLeod, 2001). Increase in blood 
ionized calcium leads to activation of CASR in the parathyroid Chief cells which 
inhibits PTH release. In the kidneys, activation of CASR leads to inhibition of calcium 
reabsorption. Thus blood ionized calcium can individually regulate functions of these 
two tissues to achieve normal blood ionized calcium level. (Grant et al., 2012).  
 
1.2.2.2.2 1,25(OH)2D3-mediated regulation 
From the BIPK axis it is clear that 1,25(OH)2D3 negatively regulates PTH levels. 
Hence deficiency of 1,25(OH)2D3 can lead to PTH overproduction (Metzger et al., 
2013). 1,25(OH)2D3 binds to the vitamin D receptor (VDR) present of the 
parathyroid Chief cells. VDR is associated with a transcriptional repressor of PTH 
(Ritter and Brown, 2011; Steingrimsdottir et al., 2005). Therefore, 1,25(OH)2D3 
binding to the VDR can down-regulate PTH expression. VDR binding of 
1,25(OH)2D3 can also mediate inhibition of proliferation of the parathyroid Chief 
cells which can lead to reduced PTH secretion. 
 
1.2.2.2.3 Phosphorous- FGF23-KLOTHO-mediated regulation  
Parathyroid hyperplasia and resulting hyperparathyroidism can lead to chronic 
kidney failure which is characterized by increased levels of plasma phosphorus 
(hyperphosphatemia) (Cozzolino et al., 2005). Hyperphosphatemia leads to binding 
of plasma phosphorus to calcium which ultimately leads to decreased blood ionized 
calcium levels and triggers PTH secretion. Fibroblast growth factor 23 (FGF23) is 
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secreted by osteocytes in response to hyperphosphatemia. FGF23 acts on the 
kidney to inhibit reabsorption of phosphorus. FGF23 binds to its receptor couple 
αKLOTHO and FGF1Rc (Hu et al., 2013). Interestingly, αKLOTHO and FGF1Rc are 
also expressed in parathyroid Chief cells. FGF23 acts through αKLOTHO and 
FGF1Rc on the parathyroid Chief cells to inhibit PTH secretion (Silver and Naveh-
Many, 2012). The integrated actions of phosphorous, FGF23, αKLOTHO, and 
FGF1Rc on the parathyroid gland Chief cells and kidney form an important 
physiological mechanism for calcium-phosphorous regulation and PTH regulation. 
 
1.2.2.3 Metabolism of PTH 
 After secretion, PTH is quickly removed from the circulation by peripheral 
clearance. PTH has a very short half-time of approximately 4-8 minutes (Koshikawa 
et al., 2010). Peripheral clearance of PTH is achieved in liver (60-70%) and kidneys 
(20-30%) (D'Amour et al., 2005; D'Amour, 2006). Hepatic clearance of PTH is 
mediated by the Kupffer cells through rapid and extensive cleavage and proteolysis 
(D'Amour et al., 1996). Renal clearance is achieved by reabsorption of PTH from the 
urine followed by PTH cleavage in the renal tubules. The small degraded fragments 
of the PTH appears in the urine ultra-filtrate (Hruska et al., 1981). Rapid renal and 
hepatic clearance of PTH ensures that the available PTH in the receptor proximity is 
exclusively determined by the PTH secretory rate.  
Metabolism of PTH also occurs within the parathyroid gland Chief cells. This 
intra-glandular metabolism involves cleavage in 33-43AA region of PTH generating 
biologically active N-terminal fragments. PTH proteolysis is regulated to generate N-
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terminal fragments which might have biological functions (Nguyen-Yamamoto et al., 
2002). Small fraction of carboxyl- and mid-region fragments of degraded PTH, which 
lack classic PTH activity, reappears in the blood. Biologically inactive fragments of 
degraded PTH via intra-glandular mechanism are also released by the parathyroid 
Chief cells. The biologic actions of carboxyl- and mid-region fragments of PTH may 
act on tissues via receptors other than classical PTH receptors (Bringhurst et al., 
1988). 
 
1.2.2.4 PTH- and PTHLH-PTH1R 
The endocrine effects of PTH and the paracrine actions of PTHLH are initiated by 
the same intrinsic plasma membrane receptor, PTH1R receptor (Mannstadt et al., 
1999). The PTH1R activates at least two major second-messenger pathways. PTH 
stimulates generation of the second messenger cyclic adenosine monophosphate 
(cAMP). The components of the PTH/PTHLH signaling pathway include one or more 
receptors that bind PTH or PTHLH and the G proteins which stimulate the respective 
enzymes adenylyl cyclase (AC) and phospholipase C (PLC) (Cupp et al., 2013). The 
PTH1R receptor is ubiquitously expressed and binds to PTH and PTHLH with equal 
affinity. On binding of either PTH or PTHLH, the PTH1R receptor activates G 
protiens leading to AC stimulation and cAMP generation. A second receptor, PTH2R 
that binds PTH but not PTHLH has already been identified (Rubin et al., 1999) with 
limited tissue distribution (Della Penna et al., 2003).  
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1.3  Calcium Sensing Regulator (CASR) 
The CASR is a type C G protein-coupled receptor (GPCR) which form 
homodimers (Ward and Riccardi, 2012). The CASR contains a large N-terminal 
extracellular calcium-binding domain. The intracellular C-terminal domain is small 
and associate with signaling proteins. The CASR has a seven transmembrane 
domain. When calcium binds to CASR it leads to receptor activation and subsequent 
activation of heterotrimeric G proteins such as Gq (Magno et al., 2011). This results 
in intracellular calcium increase and cAMP decrease in parathyroid gland Chief cells. 
Intracellular calcium release suppressed the PTH vesicle fusion with the parathyroid 
Chief cell membrane and thereby decreased PTH secretion. Deletion of G proteins, 
Gq and Gi, in mice resulted in features similar to the NSHPT, which suggested a 
possible involvement of these heterotrimeric G proteins in CASR signaling 
(Wettschureck et al., 2007).  
 
1.3.1 Isolation of Calcium Sensing Receptor 
Full-length bovine CASR was first cloned in Xenopus laevis oocytes (Brown 
et al., 1993). Human CASR cDNA was isolated from parathyroid gland Chief cells, 
parafollicular cells of thyroid gland and kidneys using hybridization-based approach 
(Ruat et al., 1995). CASR was isolated from rabbit kidneys and chicken parathyroid 
glands (Brown and MacLeod, 2001). CASRs from various species exhibit sequence 
similarity suggesting a common ancestral origin for CASR gene. Genes comparable 
to CASR (~60-70% overlap) have been identified in fishes such as salmon and shark 
(Nearing et al., 2002).  
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CASR exists as a dimer with a disulphide bond linking corresponding cysteine 
at 129 and 131 position in the extracellular domains. (Ray et al., 1999). Although the 
receptor is heavily glycosylated, glycosylation is not essential for functionality of 
CASR (Brauner-Osborne et al., 1999). Intracellular loops of the seven 
transmembrane and cytoplasmic-tail of the human CASR have five protein kinase C 
sites. Phosphorylation at threonine 888 inhibits the CASR-mediated signaling 
thereby serving a feedback regulation (Davies et al., 2007).  
Flask-shaped invaginations of the parathyroid Chief cell membrane harbor 
functional CASR dimers (Kifor et al., 1998). These invaginations are called, 
‘caveolae’. In the caveolae, cholesterol binding protein, caveolin-1, binds to CASR 
(Chakravarti et al., 2012). The C-tail of CASR associates with filamin-A, an actin 
binding protein. Filamin-A acts as a scaffold for other intracellular proteins (Pi et al., 
2002). The CASR’s ability to activate MAPK, ERK1 and ERK2 is dependent on its 
affinity to bind filamin-A. The resistance of CASR to desensitization on repetitive 
exposure to calcium is due to its binding to the cytoskeletal filamin-A. This resistance 
to desensitization of CASR is important for its calcium sensing function in various 
cell types including parathyroid gland Chief cells.  
 
1.3.2 CASR gene  
The human, rat and mouse CASR gene is located on chromosome 3 (3q13.3-
21), 11 and 16 respectively (Brown and MacLeod, 2001). There are seven exons in 
the CASR gene. The second exon contains the start codon while the last 5 exons 
code for the full-length CASR. Out of the last five exons, four exon codes for the 
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extracellular domain while the seventh exon codes for the transmembrane and 
intracellular C-terminus region.  
1,25(OH)2D3 mediates upregulation of CASR expression in the parathyroid 
Chief cells (Brown and MacLeod, 2001). High extracellular calcium also initiates 
upregulation of CASR expression in the parathyroid gland Chief cells. The high The 
upregulation of CASR expression might be responsible for the inhibition of PTH 
secretion mediated by calcium and 1,25(OH)2D3 (Brown and MacLeod, 2001).  
 
1.3.3 Functions of CASR in tissues 
1.3.3.1 Parathyroid gland 
The parathyroid glands express highest levels of CASR. CASR stimulates 
proliferation of parathyroid Chief cells. Humans with homozygous or heterozygous 
CASR inactivating mutations exhibit parathyroid hyperplasia. Similarly, mice 
homozygous for CASR inactivating mutation exhibited marked hyperparathyroidism 
and parathyroid hyperplasia (Brown and MacLeod, 2001; Liu et al., 2011).  
 
1.3.3.2 Parafollicular cells 
The parafollicular cells of thyroid gland secrete calcitonin (CT) in response to 
increased extracellular calcium. CT is responsible to reduce extracellular calcium 
through actions on bone, kidney, and intestine. CT mediates decrease in calcium 
absorption through intestine and inhibits osteoclast activity in bone. In kidneys, CT 
decreases calcium reabsorption.  Extracellular calcium activates CASR in 
parathyroid gland Chief cells to increase intracellular calcium which inhibits PTH 
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exocytosis (Brown and MacLeod, 2001). In contrast, extracellular calcium-mediated 
activation of CASR on parafollicular cells stimulates increase in CT exocytosis. 
Sequence similarity exist between CASR isolated form humans, rabbit and rat 
(Quarles, 2003). CASR in parathyroid gland helps to normalize low ionized calcium 
in blood; whereas CASR on parafollicular cells helps to normalized increased blood 
ionized calcium levels. (Fudge and Kovacs, 2004).  
 
1.3.3.3 Kidney 
In the kidney, expression of CASR is predominantly seen in the cells of the 
ascending loop of Henle. The ascending loop of Henle is responsible for the 
reabsorption of cations under the control of PTH. The CASR is also expressed in the 
cells of the distal convoluted tubule, which is involved PTH-mediated calcium 
reabsorption. In the proximal convoluted tubule, the CASR activation inhibits PTH-
induced phosphorus wasting and stimulates expression of VDR.  
 
1.3.3.4 Intestine 
PTH indirectly stimulate 1,25(OH)2D3 production which leads to increased 
calcium absorption through the intestine. The duodenum is the primary site for 
1,25(OH)2D3-mediated, trans-cellular calcium absorption (Brown and MacLeod, 
2001). The human intestine can absorbs high amounts of calcium by 1,25(OH)2D3-
dependent and independent pathways. 
The CASR regulates secretomotor functions of the GI tract to modulate GI 
motility. This regulation is seen due to the high or low levels of the calcium. 
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Activation of the CASR leads to marked reduction in fluid secretion in the colon 
(Cheng, 2012). 
 
1.3.3.5 Bone  
The concentration of calcium in the bone fluctuates during remodeling. 
Calcium underneath resorbing osteoclasts can be as high as 8-40mM (Lam et al., 
2011). High calcium concentrations may activate CASR resulting in increased 
chemotaxis of pre-osteoblasts to the recent bone resorption site in vitro. High 
calcium-mediated CASR activation also leads to proliferation of pre-osteoblasts and 
promotes their differentiation into mature osteoblasts (Sanchez-Fernandez et al., 
2008). Enhanced proliferation and differentiation increase the capacity of mature 
osteoblasts to mineralize bone proteins. However, these responses due to CASR 
activation are not documented in vivo. 
 
1.3.4 CASR signaling  
In the canonical pathway, high extracellular calcium leads to activation of CASR 
in bovine parathyroid Chief cells stimulating phosphorylation of PLC, phospholipase 
A2 (PLA2), and phospholipase D (PLD) (Breitwieser, 2013). Phosphorylation of PLC 
leads to increased production of inositol triphosphate (IP3) which binds to its 
receptor on the ER and release from the intracellular calcium (Chang et al., 2001). 
High calcium also mediates a decrease in cAMP levels in parathyroid Chief cells by 
inhibiting AC (Shoback and McGhee, 1988). High calcium-mediated CASR  
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stimulation also leads to activation of MAPKs, including ERK1/2 and p38 MAPK 
(Magno et al., 2011). 
Ubiquitously expressed (β-arrestin1 and β-arrestin2), bind to phosphorylated 
C-terminal of CASR (Fig.1.5), resulting in both an uncoupling of the receptor from its 
cognate G proteins and intracellular signaling (non-canonical pathway) (Doucette et 
al., 2009). This β-arrestin recruitment by CASR will be discussed in detail in chapter 
4. 
 
Figure 1.5: CASR signaling cascade 
PTH: parathyroid hormone, eCa2+: extracellular calcium, CASR: calcium sensing 
receptor, Gαq11: heterotrimeric G protein, PLC: phospholipase C, IP3: Inositol 
triphosphate, DAG: diacyl glycerol, PKC: protein kinase C, iCa2+: intracellular 
calcium, ERK: extracellular signal-regulated kinase, VDR: vitamin D receptor 
(complete lines: stimulation, dotted lines: inhibition). 
 
 
1.3.5 CASR agonists 
CASR agonists are classified as type I, II and III. Type I agonists are so called 
since they can stimulate CASR even in absence of calcium, a known ligand. Other 
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than calcium, CASR respond to various di- and tri-valent cations including Mg2+, Sr2+ 
and Gd3+. CASR also interacts with organic polycations, such as spermine (Brown et 
al., 1993; Brown and MacLeod, 2001). Most of the ligand receptor interactions occur 
at the extracellular domain (‘venus fly trap’ structure) of the CASR. Ca2+, Mg2+ and 
spermine, have the potential to be physiologically relevant CASR activators. In the 
microenvironments of intestine and CNS, where calcium concentrations are 
comparatively low, spermine levels are sufficiently high to activate the CASR.  
Type II agonists of CASR are also known as positive allosteric modulators (PAM) 
of CASR. Type II CASR agonists such as R567, S567, R568, S568 and Cinacalcet 
Hydrochloride are currently being used clinically to treat hyperparathyroidism. These 
are small hydrophobic molecules, which interact with transmembrane region of the 
CASR and increases CASR affinity for calcium. Type II agonists of CASR are also 
called as calcimimetics since they mimic calcium and binds at a site other than 
calcium binding site. Calcimimetics activate CASR in presence of calcium and are 
referred as ‘modular’ rather than as ‘agonists’ (Nemeth et al., 2004). Calcimimetics, 
such as R568 hydrochloride and Cinacalcet Hydrochloride, decrease PTH synthesis 
(Levi et al., 2006) and secretion (Fox et al., 1999; Nemeth et al., 1998; Nemeth et 
al., 2004), and reduce parathyroid cell proliferation (Colloton et al., 2005; Wada et 
al., 1997; Wada et al., 2000). 
Type III CASR agonists are also called as negative allosteric modulators (NAM) 
of CASR. These NAM are used in clinical trials for treatment of osteoporosis. NAM 
reduces CASR sensitivity to calcium and act pharmacologically as antagonists of the 
CASR. Hence they are also called ‘calcilytics’ (Nemeth and Shoback, 2013). 
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CHAPTER 2: SPECIFIC AIMS 
Fluoride, due to its anabolic effect on osteoblasts, was once used for treatment of 
resorptive bone diseases such as osteoporosis (Modrowski et al., 1992; Sogaard et 
al., 1997). Fluoride is no longer a treatment option for osteoporosis due to 
inconsistent outcomes. While in many cases bone mass improved there was often 
lack of concomitant improvement in bone quality. Features of skeletal fluorosis 
observed in fluoride endemic areas range from osteoporosis, osteomalacia, and 
osteosclerosis. Pseudo-hyperparathyroidism along with increased serum PTH are 
common findings in skeletal fluorosis patients (Teotia et al., 1998; Teotia and Teotia, 
1973; Wang et al., 1994). Similar findings were observed in C3H mice when they 
were exposed to 3 weeks of fluoride through drinking water. Fluoride exposures in 
C3H mice led to increased osteoclastogenesis demonstrated by an increase in 
osteoclast number and osteoclast potential along with increase in serum osteoclast 
biomarkers (such as PTH, RANKL, TRAP5b and decreased ALP and OPG) (Yan et 
al., 2007; Yan et al., 2011). However, B6 mice demonstrated increased ALP activity 
suggestive of anabolic bone changes. Therefore, C3H and B6 mice may represent 
the subset of human population demonstrating osteoporosis and osteosclerosis type 
bone lesion respectively, after fluoride exposure. Effects of fluoride on humans at 
sub-lethal/ lethal doses have been extensively researched in toxicological studies 
(Barbier et al., 2010; Dalamaga et al., 2008). However, the effects of fluoride at 
optimal/ therapeutic level to induce a catabolic response have not been studied. It is 
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also unclear what role PTH plays in fluoride-induced osteoclastogenesis in C3H 
mice. Understanding the impact of fluoride on PTH is critical due to the involvement 
of PTH in mineral homeostasis, which is tightly regulated by BPK axis (Bergwitz and 
Juppner, 2010; Lavi-Moshayoff et al., 2010; Torres and De Brauwere, 2011). 
Unfolding of the unknown mechanistic aspects of fluoride-mediated PTH modulation 
will help us to better define treatment strategies and develop drug for treatment of 
resorptive bone diseases.  
To understand the pathophysiology of fluoride-induced osteoclastogenesis we 
hypothesize that:  
Fluoride directly acts on parathyroid gland to modulate PTH secretion. 
To address this hypothesis we proposed two specific aims focused to determine the 
effect of fluoride on PTH secretion and involvement of CASR in fluoride-mediated 
PTH modulation.  
 
Sub-hypothesis 1: Fluoride leads to increased PTH secretion. 
 
Specific aim 1A: Determine a direct effect of fluoride exposure on PTH 
secretion using mice thyro-parathyroid gland organ culture (in vitro). C3H and 
B6 mice thyro-parathyroid gland organ culture were treated with fluoride. PTH levels 
in media supernatants in the fluoride treated samples were compared to untreated 
samples to determine the effect of fluoride on PTH secretion. 
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Specific aim 1B: Investigate PTH secretion in sera of C3H and B6 mice after 
single fluoride dose via oro-gastric gavage. C3H and B6 mice were given a 
single gavage dose via oro-gastric route with fluoride or distilled water and serum 
fluoride, calcium, phosphorus, magnesium, and PTH levels were measured at serial 
time points. Expression of suite of genes involved in BPK axis was determined to 
understand the effect of fluoride on PTH secretion. 
 
Sub-hypothesis 2: Effect of fluoride on PTH secretion is mediated through 
CASR.  
 
Specific aim 2A: Determine the effect of fluoride on β-arrestin recruitment in 
HTL cells transfected with human CASR cDNA. HTL cells were transfected with 
human CASR and treated with fluoride to determine arrestin recruitment in the 
transfected cells using a modification of Tango® assay (β-arrestin recruitment assay) 
to identify fluoride-mediated CASR activation.  
 
Specific aim 2B: Screen cDNA library of human orphan GPCRs to identify 
possible fluoride targets other than CASR. HTL cells were transfected with 
orphan GPCRs from class A, B, or C followed by treatment with fluoride to measure 
and compare β-arrestin recruitment after fluoride treatment to determine fluoride-
mediated receptor activation. 
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Studies focusing on experiments outlined in specific aim 1 (1A and 1B) and 
specific aim 2 (2A and 2B) are discussed in detail in Chapter 3 and 4 respectively. 
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3.1 Abstract 
Systemic fluoride induces osteoclastogenesis in C3H/HeJ (C3H) mice 
evidenced by increased serum intact parathyroid hormone (iPTH), soluble receptor 
activator of nuclear factor kappa-B ligand (sRANKL), and tartrate-resistant acid 
phosphatase 5b (TRAP5b) along with reduced levels of osteoprotegerin (OPG); 
whereas, in C57BL/6J (B6) mice fluoride’s anabolic actions are favored (Yan D. et 
al, Bone 2007). In addition, pseudo-hyperparathyroidism often accompanies 
endemic skeletal fluorosis in humans. Mechanisms that underlie fluoride’s actions on 
the parathyroid gland are not well understood. The objective of this study was to 
investigate fluoride’s effects on iPTH secretion. Thryo-parathyroid complexes (TPCs) 
from 5-6 week old C3H (n=18) and B6 (n=18) male mice were dissected, dispersed 
and cultured in medium pre-optimized for strain specific calcium, phosphorus, and 
magnesium serum levels. TPCs were treated with 0, 250 or 500µM sodium fluoride 
for 24hrs and secreted intact parathyroid hormone (iPTH) in the media assayed by 
ELISA. 5-6 weeks old C3H (n=78) and B6 (n=78) male mice were gavaged once 
with distilled or with fluoride (0.001mg [F-]/g body weight) water. At serial time points 
(0.5, 1, 3, 6, 12 or 24hrs) serum iPTH, fluoride, total calcium, phosphorus and 
magnesium levels were determined. Expression of genes involved in mineral 
regulation via bone-parathyroid-kidney (BPK) axis such as: Pth, Casr, Vdr, Pthlh, 
Fgf23, αKlotho, Fgf1rc, Tnfs11, Pth1r, Slc34a1, Slc9a3r1, Clcn5 and Pdzk1 genes 
were determined in TPCs, hummerii and kidneys at 24hrs in both strains. A dose 
dependent decrease in iPTH was seen in vitro for C3H (p<0.005) and B6 (p<0.005) 
at 500µM. Single gavage led to an increase in serum fluoride peaking at 0.5hr. iPTH 
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also peaked at 0.5hr in both C3H (p=0.002) and B6 (p=0.01) followed by a decrease 
in C3H at 24hrs (p=0.002) returning to baseline at 48hrs. At 12hrs there was an 
increase in iPTH in B6 (p<0.001) which returned to baseline at 24hrs. No significant 
changes in serum total calcium, phosphorus and magnesium were observed. We 
conclude that fluoride modulates iPTH secretion in vitro and in vivo. While fluoride’s 
effects on TPC, in vitro, were equivalent between the two mouse strains, fluoride 
demonstrated an early strain dependent effect on iPTH secretion in vivo. C3H and 
B6 mice demonstrated a difference in the expression of genes involved in BPK axis 
suggesting an underlying difference in physiologic handling of fluoride by the two 
strains. 
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3.2 Introduction 
Fluoride has recognized actions on bone homeostasis (Everett, 2011). Yan et 
al investigated in two inbred strains of mice, C3H/HeJ (C3H) and C57BL/6J (B6), 
fluoride actions on bone homeostasis (Yan et al., 2007). Short term systemic 
exposure to fluoride for C3H resulted in increased osteoclastogenesis as evidenced 
by increases in serum osteoclast biomarkers: intact parathyroid hormone (iPTH), 
soluble receptor activator of nuclear factor kappa-B ligand (sRANKL) and tartrate-
resistant acid phosphatase 5b (TRAP5b) along with decrease in serum 
osteoprotegerin (OPG) levels (Yan et al., 2007). Osteoclast numbers along bone 
surfaces and osteoclast potential of bone marrow cells were increased in C3H as 
well. However, similar fluoride exposure in B6 mice favored anabolic responses with 
increases in serum alkaline phosphatase (ALP) activity, proximal tibia trabecular and 
vertebral bone mineral density.  
PTH is responsible for calcium homeostasis and is released in response to 
hypocalcemia to normalize serum calcium levels (Potts, 2005). PTH is an important 
component of the bone-parathyroid-kidney (BPK) feedback loop responsible for 
mineral homeostasis (Bergwitz and Juppner, 2010; Torres and De Brauwere, 2011). 
Skeletal fluorosis results from systemic exposures to fluoride leading to calcification 
of ligaments, bone deformities, fractures, functional limitations, disturbed mineral 
balance and occasional pseudo-hyperparathyroidism (Teotia et al., 1998; Teotia and 
Teotia, 1973). The mechanisms underlying altered PTH levels due to fluoride 
exposure are not understood. We hypothesize that PTH secretion is influenced by 
direct effects of fluoride on the parathyroid gland. Our in vitro and in vivo 
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experiments were directed to investigate early events following fluoride exposure on 
PTH secretion. 
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3.3 Materials and Methods 
3.3.1 Animals 
Ninety-six, 5-6 week old male C3H/HeJ (C3H) and C57BL/6J (B6) mice (The 
Jackson Laboratory, Bar Harbor, ME, USA) were placed on a constant nutrition no 
fluoride diet #5861 (Test Diet®, Richmond, IN, USA; fluoride: 0ppm, calcium: 0.60%, 
phosphorus: 0.57%, Vit D3: 2.2 IU/g, and Energy: 4.09 kcal/g) and provided distilled 
drinking water, ad libitum, for one week to acclimatize. Mice were housed in The 
Division of Lab Animal Medicine facility at The University of North Carolina at Chapel 
Hill, an AAALAC accredited unit. Mice were placed in 12:12 light and dark cycles at 
21oC ambient temperature. All experimental procedures were approved by the 
Institutional Animal Care and Use Committee at The University of North Carolina at 
Chapel Hill.  
3.3.2 Parathyroid gland organ culture 
Mice were euthanized by CO2 and ventral neck dissection was performed to 
isolate and remove thyro-parathyroid complex (TPC). TPCs were finely minced and 
transferred to 2ml centrifuge tube with digestion buffer containing 1mg/mL of 
collagenase (Stem Cell Technologies, Vancouver, BC, Canada) in dispase solution 
(Stem Cell Technologies). TPC were incubated at 37oC for 3hrs with intermittent 
pipetting for homogeneous dispersion of cells. Dispersed cells were incubated at 
370C at 5% CO2 in 2ml pre-warmed alpha MEM (Sigma Aldrich, St. Louis, MO, USA) 
media with 10% FBS (Clontech Laboratories, Mountain View, CA, USA) and 1% 
antibiotic-antimycotic (Sigma-Aldrich, St. Louis, MO, USA). Total calcium, 
magnesium, and phosphorus levels in media were equivalent to that of serum in 
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each strain of mice: C3H (calcium: 10.6mg/dL, phosphorus: 8.7mg/dL, and 
magnesium: 2.1mg/dL) and B6 (calcium: 10.4mg/dL, phosphorus: 10.3mg/dL, and 
magnesium: 2.9mg/dL). The TPC from C3H and B6 were randomly divided into 3 
groups (n=6) based on fluoride concentrations 0, 250 or 500µM. Media supernatants 
were collected at 24hrs and stored at -80oC. 
3.3.3 Gavage and sample collections 
Following acclimatization, mice from both strains were randomly divided in 6 
groups based on time of sacrifice after gavage dose. Mice were further divided into 
control and test group (n=6) based on fluoride levels (0 or 100ppm) in gavage. Both 
the groups of mice were sacrificed at 0.5, 1, 3, 6, 12 or 24hrs. At the time of gavage, 
mice were weighed and the gavage dose was calculated for each mouse (0.001mg 
[F-]/g body weight). Mice were anesthetized with ketamine-HCl (90mg/kg) and 
xylazine (14mg/kg) i.p. 15mins prior to the determined time of sacrifice. Sera were 
collected from mice and stored at -80oC until use. TPCs, kidneys, and humerii were 
harvested, snap-frozen in liquid nitrogen, and stored at -80oC.  
3.3.4 ELISA and biochemistry assays 
Media supernatants and sera were analyzed for iPTH using 1-84 PTH ELISA 
kits (Immutopics, San Clemente, CA, USA). The intra- and inter-assay precision 
(coefficient of variation) for PTH ELISA was 3.2 and 8.4, respectively. Serum levels 
of fluoride were determined using direct fluoride microanalysis method (Vogel et al., 
1990). In this method micropipettes pulled from glass capillary tubes are combined 
with a custom-made micro-pipette holder and used to dispense nanoliter-sized 
standards and serum samples (diluted 9:1 with TISAB III). Serum samples are 
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extracted over a light table using the micropipette/micropipette holder and dispensed 
onto the surface of an inverted fluoride electrode (F-ISE) under a layer of mineral oil 
to prevent loss of fluoride. Using a micromanipulator and microscope for viewing, the 
reference electrode is touched to the standard or sample drop, resulting in an 
electrometer mV reading. Both the F-ISE and hand-pulled reference electrode are 
connected to an electrometer and computer with plot program monitoring/recording 
software.  Samples are run in triplicate, with periodic electrode conditioning and 
standard checks. Calcium, phosphorus, and magnesium were determined by the 
Animal Clinical Laboratory, University of North Carolina at Chapel Hill and the 
Clinical Pathology Laboratory, College of Veterinary Medicine at North Carolina 
State University. 
3.3.5 RNA extractions and cDNA preparation 
RNA was extracted from 24hrs TPCs, kidneys, and humerii samples using 
RNeasy Midi kit (Qiagen Inc., Valencia, CA, USA). Quantitative analysis of RNA 
sample was performed using Agilent Bioanalyzer using Nano Labchip at the 
Genomic Core Facility, University of North Carolina at Chapel Hill. All RNA sample 
had RIN values 7.5-10 range. High Capacity Reverse transcription kit (Applied 
Biosciences, Carlsbad, CA, USA) was used to prepare cDNA. After preparation, 
cDNA was stored at -80oC. 
qPCR 
cDNA samples free of genomic DNA contamination were subjected to qPCR for 
suite of genes including parathyroid hormone (Pth), calcium sensing receptor (Casr), 
alpha-Klotho (αKlotho), fibroblast growth factor receptor 1c (Fgf1rc), vitamin D 
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receptor (Vdr), parathyroid hormone like hormone (Pthlh), tumor necrosis factor 11 
(Tnfs11), fibroblast growth factor 23 (Fgf23), parathyroid hormone receptor 1 (Pth1r), 
chloride channel 5 (Clcn5), Solute carrier 9 member 3 regulator 1 (Slc9a3r1), PDZ 
domain containing 1 (Pdzk1) and Solute carrier family 34 member 1 (Slc34a1). 
Expression of these genes was normalized using two house-keeping genes 
comprising of beta actin (Actb) and glyceraldehyde 3-phosphate dehydrogenase 
(Gapdh). All the primers were ordered from SA Biosciences (Qiagen Inc., Valencia, 
CA, USA). Data were analyzed using 2-∆∆Ct method as previously described (Livak 
and Schmittgen, 2001; Yuan et al., 2006). 
3.3.6 Statistical analysis 
Data were reported as mean ± SE. Statistical analyses were performed using 
one-way ANOVA followed by Bonferroni as a post hoc test. For the in vitro 
experiments, six groups were compared based on strain (C3H or B6) and levels of 
fluoride exposure (0, 250 or 500µM). For the in vivo experiments 28 groups were 
compared based on strain (C3H or B6), levels of fluoride exposure (0 or 100ppm) 
and time points (0, 0.5, 1, 3, 6, 12 and 24hrs). SPSS statistics 18 software (SPSS 
Inc., Chicago, IL, USA) was used for statistical analysis. Adjusted p-values ≤0.05 
were considered significant. 
 
 
 
 
 
 3.4 Results 
3.4.1 Responsiveness of TPC organ culture model
 The TPC organ culture model was 
effects of fluoride on the 
model to changes in the extracellular
determined, was used to validate the culture model
calcium concentrations (hypocalcemic: 
hypercalcemic: 25mg/dL) demonstrated changes in iPTH secretion into the media
Figure 
(A) iPTH ± SE (pg/mL) in C3H TPCs at three calcium concentrations; 1.1, 10.5 or 
25mg/dL (n=3 in each group). (B) iPTH ± SE (pg/mL) in C3H and B6 TPCs after 
24hrs of incubation at three fluoride concentrations; 0, 250 or 500µM (grey bar=C3H 
and black bar=B6, n=6 in each group; **p<0.005).
 
After 24hrs of incubation at hypocalcemic condition, iPTH secretion 
(129.43±27.14pg/mL) was significantly increased (
normocalcemic condition (49.28±6.21pg/mL) 
conditions lead to a modest iPTH decline. Although not shown, TPCs in culture 
remain responsive to changes in calcium for 3 days. 
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utilized in order to determine 
parathyroid gland. Responsiveness of the organ culture 
 calcium, a known PTH 
. TPCs cultured
1.1mg/dL, normocalcemic: 
3.1: iPTH levels in media supernatant 
 
p<0.001) as compared to the 
(Fig. 3.1A). The hypercalcemic 
 
the direct 
mediator was 
 in varying 
10.5mg/dL or 
.  
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3.4.2 Effect of fluoride on TPCs 
 TPCs from B6 and C3H mice were then cultured in media normalized with 
calcium, phosphorus, and magnesium levels present in the sera for each strain 
followed by treatment with varying fluoride concentrations (0, 250 or 500µM). Media 
supernatants were collected at 24hrs and iPTH determined. TPCs from C3H 
demonstrated a significant (p<0.001) decrease in iPTH with increasing fluoride 
concentration from 0µM (128.53±10.60pg/mL) to 250µM (86.20±12.47pg/mL, 
p<0.001) or 500µM (52.33±8.94pg/mL, p<0.001). TPCs from B6 demonstrated less 
decrease in iPTH with increasing fluoride concentrations from 0µM 
(64.37±14.78pg/mL) to 250µM (50.99±12.22pg/mL) or 500µM (38.12±5.19pg/mL) 
and reaching significance at 500µM fluoride concentration (p<0.001) (Fig. 3.1B).  
3.4.3 Serum fluoride levels after gavage 
 A calculated dose of fluoride was delivered by oro-gastric gavage. Serum 
fluoride concentrations were measured at serial time points (0.5, 1, 3, 6, 12 or 24hrs) 
after a single gavage dose. The fluoride levels in the serum peaked in both strains, 
C3H (61.05±5.67µM) and B6 (26.74±3.17µM), at 0.5hr (p<0.005) after gavage. 
Fluoride levels reached baseline in C3H (8.75±1.76µM) and B6 (3.57±0.42µM) after 
6-9hrs (Fig. 3.2). Both the strains, C3H and B6 demonstrated a similar pattern of 
fluoride kinetics. However, fluoride levels in B6 were lower than C3H at each serial 
time point (p<0.005) examined. The peak fluoride concentration in C3H 
(61.05±5.67µM) was nearly three times that compared to B6 (26.74±3.17µM).  
 Figure 
Mean serum fluoride (F) ± SE (µM) 
mice sacrificed at serial time points; 0.5, 1, 3, 6, 12 or 24hrs compared to baseline 
(no gavage), (grey bar=C3H and black bar=B6) (n=6 in each group; **p<0.005).
 
3.4.4 Serum iPTH after single fluoride
 Serum iPTH was measured at 
C3H and B6 mice after fluoride
an equal volume of 0ppm 
serum iPTH levels increased
and B6 (149.91±21.24pg/mL, 
(C3H: 196.15±21.45pg/mL
fluoride gavage) (C3H: 244.49±35.52pg/mL
the C3H strain iPTH dropped below baseline at 24h
(Fig. 3.3A); whereas, in B6, iPTH increase
and then returned to baseline at 2
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3.2: Serum fluoride levels 
after 100ppm fluoride gavage in C3H and B6 
 dose via oro-gastric gavage
various time points (0.5, 1, 3, 6, 12 or 24hrs) 
 gavage (0.001mg [F-]/g body weight) 
fluoride water. At 0.5hr after 100ppm fluoride 
 significantly for C3H (358.44±19.44pg/mL,
p=0.01) as compared to baseline untreated 
 and B6:  114.13±27.43pg/mL) or control 
 and B6: 98.616±6.45pg/mL
rs (82.07±10.71pg/mL
d at 12hr (176.99±20.82pg/mL
4hrs (95.65±19.91pg/mL) (Fig. 3.
 
 
 
in 
or gavage with 
gavage, 
 p=0.002) 
levels 
levels (0ppm 
) groups. In 
, p=0.002) 
, p<0.001) 
3B). The peak 
 iPTH value in C3H (358.44±19.44pg/mL
(176.99±20.82pg/mL).  
Figure 
Mean serum iPTH ± SE (pg/mL) after 0 or 100ppm fluoride gavage in C3H (A) and 
B6 (B) mice sacrificed at serial time points; 0.5, 1, 3, 6, 12 or 24hrs compared to 
untreated mice (hatched bar=untreated/ baseline group, white bar=0ppm group and 
black bar=100ppm group) (n=6 in each group; *p<0.05, **p<0.005). 
 
Since the iPTH levels 
points were collected. The serum iPTH 
returned to baseline at 48
fluoride’s effects on iPTH secretion in two mice strains; C3H and B6
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) was twice that of peak iPTH values in B6 
3.3: Serum iPTH levels 0-24 hrs 
 
in C3H dropped below baseline at 24hrs 
in C3H after single 100ppm fluoride 
hrs (Fig. 3.4). These data demonstrated 
. 
 
additional time 
gavage 
a difference in 
 Figure 
Mean serum iPTH ± SE (pg/mL) after 0 or 100ppm fluoride gavage in C3H 
harvested at extended time points; 48, 72 or 96hr compared to untreated mice 
(hatched bar=untreated/ baseline group, white bar=0ppm group and black 
bar=100ppm group) (n=6 in each group; 
 
3.4.5 Serum total calcium
 Serum total calcium
fluoride gavage mice in both C3H 
a significant reduction (C3H: 
at 0.5hr in 100ppm fluoride gavage group (C3H: 8.7±0.2mg/dL and B6: 
8.5±0.2mg/dL) as compared to 0ppm control (C3H: 8.9±0.1mg/dL and B6: 
9.5±0.2mg/dL) or untreated baseline group (C3H: 9.3±0.1mg/dL
9.2±0.2mg/dL). 
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3.4: Serum iPTH levels 48-96hrs 
**p<0.005).  
, phosphorus, and magnesium levels
 levels were relatively consistent between 0 and 100ppm 
(Fig. 3.5A) and B6 mice (Fig. 3.5D)
p=0.013 and B6: p=0.001) in serum total calcium only 
 
 
. We observed 
 and B6: 
  Variations were relatively common for serum phosphorus levels for both C3H 
(Fig. 3.5B) and B6 (Fig. 3.5E)
differences between 0 and 100ppm fluoride gavage mice at all observed time 
Figure 3.5: Serum calcium, phosphorus, and magnesium levels
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 mice. But there were no statistically significant 
points.  
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Mean serum calcium (Ca) ± SE, phosphorus (Pi) ± SE and magnesium (Mg) ± SE 
(mg/dL) after 0 or 100ppm fluoride gavage in C3H (A, B and C respectively) and B6 
(D, E and F respectively) harvested at serial time points; 0.5, 1, 3, 6, 12 or 24hrs 
(hatched bar=untreated/ baseline group, white bar=0ppm group and black 
bar=100ppm group) (n=6 in each group; *p<0.05, **p<0.005). 
 
Although serum magnesium levels were relatively stable, minor variations were 
seen for both C3H (Fig. 3.5C) and B6 (Fig. 3.5F) mice. Similar to phosphorus, no 
statistically significant differences were observed in magnesium levels between 0 
and 100ppm fluoride gavage mice at all observed time points. 
3.4.6 qPCR: Expression of genes involved in BPK feedback loop 
 We investigated the expression of various genes involved in the BPK 
feedback loop using TPC, humerii and kidneys. Expression of the genes in the 
tissues obtained from 100ppm fluoride gavage C3H and B6 mice group at 24hrs 
were normalized with an average of two house-keeping genes (Actb and Gapdh). 
Gene expression was further normalized to control 0ppm fluoride gavage group and 
fold difference of genes in TPC (Fig. 3.6A), humerii (Fig. 3.6B) and kidneys (Fig. 
3.6C) were calculated for C3H and B6 mice using 2-∆∆Ct method. In TPC, Pth 
(p=0.001), Casr (p=0.012), αKlotho (p=0.003), Fgf1rc (p=0.035), Vdr (p=0.001) and 
Pthlh (p=0.03) were significantly up-regulated in C3H as compared to B6. In humerii, 
only Pthlh (p=0.001) was significantly up-regulated in C3H as compared to B6 mice. 
In kidney, Pth1r (p=0.005), Clcn5 (p=0.003), αKlotho (p=0.05), Fgf1rc (p=0.004) and 
Slc9a3r1 (p=0.04) were significantly down-regulated in C3H as compared to B6. 
 
 Figure 3.6: Expression of genes involved in BPK feedback loop
Fold-difference ± SE in C3H and B6 100ppm fluoride gavage group normalized to 
control, 0ppm fluoride group and house
TPCs (A), humerii (B) and kidneys (C). (grey bar=C3H and black bar=B6) (n=6 in 
each group; *p<0.05, **p<0.001).
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-keeping gene pool (Actb and Gapdh
 
 
) in 
68 
 
3.5 Discussion 
Skeletal fluorosis is characterized by a spectrum of radiographic bone changes 
ranging from osteoporosis to osteosclerosis (Wang et al., 1994). Although, clinical 
cases of skeletal fluorosis are rare in the United States  (Kurland et al., 2007; Whyte 
et al., 2008) in other parts of the world where skeletal fluorosis is more common 
patients often demonstrate pseudo-hyperparathyroidism (Gupta et al., 2001; Koroglu 
et al., 2011; Teotia et al., 1998; Teotia and Teotia, 1973; Xu et al., 2010). 
Epidemiologic studies show that individuals of the population exposed to similar 
fluoride levels demonstrate variable skeletal features ranging from excessive bone 
formation to bone resorption (Harinarayan et al., 2006; Teotia et al., 1998). 
Therefore, the mechanisms that underlie fluoride’s actions on the bone and PTH are 
not clearly understood. Yan et al demonstrated a link between fluoride exposure and 
iPTH levels using the C3H and B6 inbred strains of mice (Yan et al., 2007). Fluoride 
exposure in C3H led to enhanced osteoclastogenesis including elevated serum 
iPTH, whereas in B6 an anabolic action of fluoride was favored. Additionally these 
strains are widely studied for their differences in bone biology. C3H mice have high 
bone mass, peak bone density and alkaline phosphatase activity and low bone 
resorption capacity as compared to B6 mice (Chen and Kalu, 1999; Linkhart et al., 
1999; Turner et al., 2000; Turner et al., 2001).  
 Direct or indirect effects of fluoride on the parathyroid gland have not been 
investigated. We developed a murine TPC organ culture model using strains with a 
predictable iPTH secretion response to changes in calcium. Similar TPC organ 
culture models have been employed using bovine, human and rat parathyroid 
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tissues to study parathyroid hormone regulation (Nakajima et al., 2010; Nielsen et 
al., 1996; Wongsurawat and Armbrecht, 1987). Calcium, phosphorus, and 
magnesium are known to mediate changes in iPTH secretion and therefore, the 
levels of these in the media were kept equivalent with strain specific serum levels to 
prevent unwanted effects on iPTH secretion. In both C3H and B6 fluoride exposure 
resulted in dose dependent reductions in iPTH secretion into the media measured at 
24hrs. This reduction was more evident for C3H which at baseline secretes almost 
twice the iPTH as compared to B6. 
The fluoride kinetics observed for B6 and C3H strains were consistent with 
previous studies where serum fluoride reaches a peak within 20-30mins (Ekstrand et 
al., 1977; Whitford, 1994). It is generally accepted that after absorption, fluoride is 
incorporated in newly mineralized bone or is excreted in the urine resulting in decline 
of serum levels reaching baseline by 6-8hrs (Ekstrand et al., 1980). In order for 
fluoride to elicit a rapid iPTH response it is hypothesized that fluoride interacts with 
the parathyroid gland directly through modulating iPTH release from vesicles in the 
Chief cells. The exact molecular mechanism of this response is not understood. 
However, our in vitro findings suggest the presence of such a direct interaction of 
fluoride on the parathyroid glands.  
In the current study, C3H mice have higher baseline serum iPTH compared to 
B6. This is consistent with our TPC baseline values. C3H mice are more responsive 
to the single fluoride exposure perhaps because reaching a higher peak serum 
fluoride level. This enhanced response is shown after the gavage when the levels of 
iPTH were higher in C3H as compared to B6. At 24hrs iPTH levels were lower than 
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baseline for both strains. Both strains also showed bimodal responses to fluoride. 
For C3H, iPTH peaks at 0.5hr and declines below the baseline at 12hrs reaching a 
nadir at 24hrs then over the next 24hrs returns to baseline and remains at baseline 
at 96hrs. B6 mice show a similar but lower magnitude of response.  
The modulation of iPTH secretion as a response to fluoride exposure may also 
be mediated by changes in calcium levels. Decreased serum calcium levels after 
acute hydrofluoric acid inhalation has been documented in humans (Zierold and 
Chauviere, 2012). Acute exposure to fluoride through injection of hydrofluoric acid 
(1.6mg/Kg) in rats led to a decrease in serum ionized calcium and total calcium after 
30 and 300mins respectively (Santoyo-Sanchez et al., 2013). Similar decrease in 
plasma calcium was observed in rats due to acute fluoride exposure (Imanishi et al., 
2009). The reduced serum calcium is hypothesized to be due to the formation of 
CaF2 complexes resulting into a net reduction in calcium levels leading to a 
hypocalcemic response. In our study, we observed a transient decrease in calcium 
in both strains of mice only at 0.5hr with return to baseline within 1hr. There were no 
significant changes in phosphorus and magnesium at any time point.  
BPK feedback loop has been extensively studied to understand the interaction of 
various genes involved in mineral homeostasis. The cross-talk between the bone, 
parathyroid and kidney is responsible for effective regulation of minerals. The effect 
of fluoride on these individual tissues after a single fluoride dose in these two strains 
of mice will help us to understand the effect of fluoride on regulatory aspects of 
mineral homeostasis. Change in gene expression patterns due to fluoride exposure 
have been studied in the past (Li and DenBesten, 1993; Nair et al., 2011; Pei et al., 
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2012) but our study has focused only on expression of the genes involved in calcium 
and phosphorus homeostasis and are part of BPK feedback loop. Fold differences in 
expression of Pth, Casr, αKlotho, Fgf1rc, Vdr and Pthlh in TPCs suggests that at the 
molecular level fluoride has a differential impact on parathyroid tissues in C3H and 
B6. The expression of these genes reflects a compensatory mechanism to counter 
changes in iPTH secretion. It is clear that fluoride effects are not limited to Pth but 
extends to Pth homologues such as Pthlh. Expression of Fgf1rc-αKlotho (receptor 
couple for Fgf23) and Pth1r are suggestive of an effort to intercept conservation of 
calcium and excretion of phosphorus in the kidneys to achieve homeostasis after 
initial iPTH secretion. Overall, there exists a difference in expression of BPK genes 
in the two strains of mice. This suggests a difference in physiologic handling of 
fluoride by the two strains. It will be interesting to study the effect of repeated fluoride 
dose on expression of the key genes in C3H and B6. 
Our study investigated the early events involved in fluoride interaction on 
parathyroid gland in vitro and in vivo. Fluoride can act on the parathyroid gland 
directly to modulate iPTH secretion in vitro and in vivo. It is still not clear if the 
decrease in total serum calcium level is responsible for fluoride-mediated iPTH 
modulation. The effect of fluoride on iPTH secretion is rapid and observable even 
after single fluoride dose. The overall effects of fluoride are not limited to parathyroid 
gland but changes in expression of genes involved in BPK feedback loop suggest a 
broader impact of fluoride on multiple aspects of bone metabolism. 
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4.1 Abstract 
Fluoride exposure in C3H and B6 mice led to a decrease in parathyroid hormone 
(PTH) secretion in vitro and in vivo. (Puranik et al, Chapter 3) Fluoride both 
enhances polyphosphoinositide (PPI) breakdown and reduces agonist-stimulated 
cAMP accumulation, resulting in inhibition of PTH release in vivo (Blackmore et al, 
1986). Fluoride is known to activate signaling pathways including GPCR pathway. 
Calcium sensing receptor (CASR), a GPCR, present on varieties of cells including 
Chief cells of the parathyroid gland are responsible for extracellular calcium sensing 
and PTH regulation. It is not clear if the CASR is involved in fluoride-mediated PTH 
modulation. This study aims to investigate the role of CASR in fluoride-mediated 
PTH modulation. We also screened 126 human orphan GPCRs, for which ligands 
have not been identified, to identify fluoride as plausible ligand for receptor 
activation. We used HTL cells transiently transfected with human CASR or 126 
orphan GPCRs constructs. Cells were treated with sodium fluoride for 16hrs in 
increasing dilutions. Activation of the GPCRS was determined using a modified 
Tango® assay (β-arrestin recruitment assay). Calcimimetic compound R568 
hydrochloride (R568) which is a positive allosteric modulator of CASR was used as a 
control. We demonstrated that in R568 exhibited inverse agonist activity through 
non-canonical pathway in HTL cells transfected with human CASR. Fluoride 
treatment of HTL cells transfected with CASR did not demonstrate any change in β-
arrestin recruitment. Moreover, sodium fluoride did not alter R568-mediated 
response in HTL cells. Among the 126 screened orphan GPCRs from class A, B, or 
C only three GPCRs: GPR111, GPR142, and GPRC5D demonstrated increased β-
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arrestin recruitment (>200%) after fluoride treatment as compared to untreated cells.  
The study concluded that the effect of fluoride to modulate PTH secretion is 
independent of CASR. Additionally, the study identified ubiquitously expressed 3 
candidate GPCRs which might be involved in fluorides actions on the cells. Further 
investigation of the candidate orphan GPCRs will be valuable in understanding the 
mechanistic aspects involved in fluoride metabolism.   
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4.2 Introduction 
 It is important for the cellular functioning to respond promptly and efficiently to 
the changes in the extracellular environment. Transmembrane receptors are evolved 
to effectively relay the extracellular signals through the plasma membrane and 
generate intracellular signal. Fluoride is known to stimulate a rapid dose-dependent 
increase in IP3, a potent intracellular calcium mobilizing compound (Shoback and 
McGhee, 1988). Fluoride also activates GTP-dependent processes in the 
parathyroid gland Chief cells which leads to the breakdown of PPI and accumulation 
of cAMP (Shoback and McGhee, 1988) which may lead to suppression of PTH 
secretion. Our study demonstrated that fluoride exposure leads to a decrease in 
PTH in a murine model, in vitro and in vivo (Puranik et al, Chapter 3). The CASR, a 
membrane bound GPCR present on the Chief cells of the parathyroid glands, 
mediates intracellular signaling events required for decrease in PTH secretion 
(Brown and MacLeod, 2001; Magno et al., 2011; Ward and Riccardi, 2012). 
Evidence from other secretory systems suggests that intracellular calcium 
dependent exocytosis involves GPCRs (Berridge and Irvine, 1984). Fluoride is 
known as an activator of signaling pathways including GPCR pathway (Downs et al., 
1980). Fluoride both enhances PPI breakdown and reduces agonist-stimulated 
cAMP accumulation, resulting in inhibition of PTH release in vivo (Blackmore and 
Exton, 1986). There are reports suggesting that fluoride stimulates PLC-mediated 
PPI breakdown through G-protein activation in various types of cells, including 
parathyroid cells (Blackmore et al., 1985; Taylor et al., 1986). Whether fluoride 
stimulates the activation of CASR to decrease PTH secretion is not known. Similarly, 
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presence of any receptor for sensing extracellular fluoride has not been identified 
yet. GPCR represents the largest class of receptors. Out of known 900 GPCRs more 
than 133 GPCRs are termed orphan receptors due to unidentified ligands (Chung et 
al., 2008; Ozawa et al., 2010; Vardy and Roth, 2013). Deorphanization is the 
process of identifying the functions and ligands for a specific orphan GPCRs (Tang 
et al., 2012). In the study we investigated the role of human CASR in fluoride-
mediated inhibition of PTH secretion. We also screened the library of human orphan 
receptors from class A, B, or C to determine fluoride interaction and intracellular 
signaling.  
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4.3 Material and Methods 
4.3.1 CASR and orphan GPCRs constructs 
Human CASR cDNA and cDNa library of class A, B, and C orphan receptors 
(IUPHAR class A database; IUPHAR class B database; IUPHAR class C 
database) δ-OR constructs were codon optimized for mammalian expression and 
synthesized by Blue Heron Biotech (Bothell WA, USA) and inserted into the modular 
vector system (Barnea et al., 2008) with all constructs confirmed by automated 
dsDNA sequencing.  
4.3.2 Cells and transfection 
HEK293T-derived cell line which contains a stably integrated tTA-dependent 
luciferase reporter commonly known as HTL cells were used for these experiments 
(HTL cells were generously provided by Dr. Richard Axel to the Roth Lab). HTL cells 
were cultured in the Dulbecco’s Modified Eagle Medium (Life Technologies, Grand 
Island, NY, USA) which was supplemented with 1-2% dialyzed FBS (Life 
Technologies, Grand Island, NY, USA) in a 15cm tissue culture dish (9X106 cells in 
20mL) and incubated at 37oC at 5%CO2. HTL cells were transiently transfected with 
expression plasmids encoding CASR or orphan GPCRs using calcium phosphate as 
described earlier (Cozens et al., 1992a; Cozens et al., 1992b; Gruenert et al., 1988; 
Kingston et al., 2001). Briefly, 20µg of target receptor (CASR or orphan receptor) 
and 2µg of YFP control were mixed with CaCl2 in 0.1X TE and 2X HEPES buffer and 
incubated. The mix was then added to the cells followed by overnight incubation in 
the media containing 1% dialyzed FBS. Cells were trypsinized and counted after 
washing with PBS. Cells were plated in Poly-L-Lys (PLL) coated 384-well white clear 
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bottom (2X104 cells/50µL/well) in 384 well plates (Greiner bio-one, Frickenhausen, 
Germany). Sodium fluoride or calcimimetic, R568 hydrochloride (Tocris Bioscience, 
Bristol, UK) ligand solutions were prepared in filtered assay buffer (20 mM HEPES, 
1X Hanks’ balanced salt solution (HBSS), pH 7.40) at 3.5X and added to cells (20µl 
per well) for overnight incubation (16-20hrs) in medium containing desired calcium 
concentration  
4.3.3 β-arrestin recruitment assay 
β-arrestin recruitment assays were performed using previously described 
modifications of the original Tango® assay (Barnea et al., 2008) as described 
previously (Allen et al., 2011; Carlsson et al., 2011). Briefly, the ligand binding 
mediates recruitment of arrestin-TEV protease complex leading to a proteolytic 
cleavage at the receptor c-terminus. The proteolytic cleavage frees tTA which then 
localizes to the nucleus and activate reporter genes. Most GPCRs demonstrate 
arrestin recruitment after ligand binding through non-canonical pathway and hence 
arrestin recruitment assay can serve as a functional assay to screen the receptor 
activation after ligand binding. After overnight incubation with ligand (16-20hrs), 
media and ligand solutions were removed and 20µl per well of Bright-Glo reagent 
(Promega, Madison, WI, USA) was added (1:20 dilution in assay buffer). Plates were 
incubated for 20min at room temperature in the dark before being counted using a 
TriLux luminescence reader (PerkinElmer, Waltham, MA, USA) at 1s/well speed.  
4.3.4 Statistical analysis 
Data of four independent experiments (n=4) performed in quadruplicate were 
presented as Relative Luminescence Unit (RLU). Data were subjected to non-linear 
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least-squares regression analysis using the sigmoidal dose-response function 
provided in GraphPad Prism 6.0 (La Jolla, CA, USA).  
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4.4 Results 
4.4.1 Effect of fluoride on human CASR 
Transiently transfected HTL cells with CASR were treated with increasing dilution 
of sodium fluoride in presence of five concentrations of media calcium (0, 2.5, 5, 10, 
or 20mM). It was noted that all media calcium concentrations, fluoride did not 
demonstrate any dose-dependent change in β-arrestin recruitment as witnessed by 
comparatively unchanged relative luminescence (Fig.4.1).  There was a difference in 
β-arrestin recruitment based on difference in media calcium concentration. However, 
the overall effect of fluoride at any given calcium concentration was not different.   
 
Figure 4.1: Effect of fluoride on CASR 
HTLA cells transfected with human CASR were treated with fluoride under five 
calcium concentrations in media: 0mM (white), 2.5mM (red), 5mM (blue), 10mM 
(brown), and 20mM (yellow). Fluorescence measured in relative luminescence units 
(RLU±SE) from four experiments are shown in graph. 
 
4.4.2 Effect of calcimimetic (R568) on human CASR 
 We noticed the effect of media calcium on the CASR β-arrestin recruitment 
assay. Therefore, we screened the effect of known agonist of CASR, R568 
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hydrochloride (R568), on β-arrestin recruitment by CASR through non-canonical 
pathway. R568 is a known positive allosteric modulator of CASR. We used R568 in 
increasing dilution at five different media calcium concentration (0, 2.5, 5, 10, or 
20mM). R568 at all media calcium concentration displayed an inverse agonist 
activity on CASR (Fig. 4.2). The IC50 concentration at five different media calcium 
concentrations (0, 2.5, 5, 10, or 20mM) was 1.59e-6M, 1.46e-6M, 2.21e-6M, 1.98e-
6M, and 3.35e-6M respectively. 
 
Figure 4.2: Effect of calcimimetic (R568) on CASR 
HTLA cells transfected with human CASR were treated with R568 under five calcium 
concentrations in media: 0mM (white), 2.5mM (red), 5mM (blue), 10mM (brown), and 
20mM (yellow). Fluorescence measured in relative luminescence units (RLU±SE) 
from four experiments are shown in graph. 
 
4.4.4 Effect of fluoride on R568-mediated CASR response  
We screened the effect of sodium fluoride on R568-mediated CASR response. Β-
arrestin recruitment was detected in presence of R568 with increasing sodium 
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fluoride dilutions (0, 100, 250, 500, or 1000µM). Sodium fluoride at any 
concentration did not modulate the R568-mediated CASR response (Fig. 4.3).  The 
IC50 concentrations at five different media fluoride concentrations (0, 100, 250, 500, 
or 1000µM) were 1.81e-6M, 1.57e-6M, 1.96e-6M, 1.85e-6M, and 1.75e-6M 
respectively. 
 
Figure 4.3: Effect of fluoride on R568-mediated CASR response 
HTLA cells transfected with human CASR were treated with R568 under five fluoride 
concentrations in media: 0µM (white), 100µM (red), 250µM (blue), 500µM (brown), 
and 1000µM (yellow). Fluorescence measured in relative luminescence units 
(RLU±SE) from four experiments are shown in graph. 
 
4.4.5 Effect of R568 on CASR is specific 
 R568 demonstrated an inverse agonist response on CASR therefore, we 
validated this response. CASR-unrelated GPCRs, dopamine receptor D2 and D3 
(DRD2 and DRD3) were selected and treated with increasing dilution of R568 alone, 
quinpirol (known ligand for DRD2 and DRD3) alone or R568 and quinpirol both using 
β-arrestin recruitment assay. Quinpirol demonstrated a predictable increase in 
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luminescence suggestive of β-arrestin recruitment in both DRD2 and DRD3. 
However, R568 did not demonstrate any β-arrestin recruitment alone, suggesting 
that R568 response is valid and specific to CASR (Fig. 4.4). 
 
Figure 4.4: Effect of R568 on CASR is specific 
  
HTLA cells transfected with human DRD2 and DRD3 were treated with known 
agonist of DRD2 and DRD3, quinpirol alone, calcimimmetic R568 alone, and both 
quinpirol and R568 both. Fluorescence measured in relative luminescence units 
(RLU±SE) from four experiments are shown in graph. 
 
4.4.5 Effect of R568 extends to CASR related GPCRs 
GPRC6A, is ubiquitously expressed in the human body and is a membrane 
bound receptor involved in calcium sensing. We screened the effect of R568, a 
calcimimetic on GPRC6A. GPRC6A was treated with increasing dilution of R568 to 
determine the impact on β-arrestin recruitment at five different media calcium 
concentrations (0, 2.5, 5, 10, or 20mM). R568 at all media calcium concentrations 
displayed an inverse agonist activity on GPRC6A too (Fig. 4.5). The IC50 
concentration at five different media calcium concentrations (0, 2.5, 5, 10, or 20mM) 
was 8.40e-1M, 1.85e-6M, 1.23e-5M, 1.05e-5M, and 3.79e-1M respectively. 
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Figure 4.5: Effect of R568 on GPRC6A 
  
HTLA cells transfected with human GPRC6A were treated for 16hrs with R568 under 
five calcium concentrations in media: 0mM (white), 2.5mM (red), 5mM (blue), 10mM 
(brown), and 20mM (yellow). Fluorescence measured in relative luminescence units 
(RLU±SE) from four experiments are shown in graph. 
 
4.4.6 Effect of fluoride on 126 orphan GPCRs 
We screened 126 GPCRs from class A, B, or C orphan GPCRs using β-arrestin 
recruitment assay. Relative luminescence values were determined from fluoride 
treated and untreated cells. Percentage RLU was calculated using the formula: 
%RLU= RLU from fluoride treated wells/ RLU from fluoride untreated wells (Table 
4.1). Percentage RLU values more than 200 were considered significant. After 
fluoride treatment, out of the 126 screened human orphan GPCRs, only three 
GPCRs demonstrated percentage RLU >200. Additional information regarding the 3 
orphan GPCRs demonstrating activation due to fluoride is outlined in Table 4.2. 
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GPCR %RLU GPCR %RLU GPCR %RLU GPCR %RLU 
GPR1 149.86 GPR111 258.89 GPRC5B 134.51 SUCN1 97.54 
GPR3 109.16 GPR113 171.54 GPRC5C 90.80 TA1 92.27 
GPR4 120.95 GPR114 144.20 GPRC5D 226.05 TAAR2 79.60 
GPR6 93.34 GPR115 138.48 GPRC6A 113.50 TARR5 64.35 
GPR12 72.79 GPR116 131.96 HCA1 162.89 TAAR6 115.58 
GPR15 121.36 GPR119 95.70 HCA2 102.64 TARR8 81.74 
GPR17 96.57 GPR123 128.30 HCA3 67.12 TAAR9 88.59 
GPR19 141.49 GPR124 116.51 LPA4 125.11 CCR1 55.96 
GPR20 142.03 GPR125 153.57 MAS1 125.03 CCR2 115.92 
GPR26 96.77 GPR126 106.69 MAS1L 118.75 CCR3 95.46 
GPR32 110.23 GPR132 109.92 MRGPRD 111.31 CCR4 109.65 
GPR34 86.18 GPR133 128.13 MRGPRE 176.81 CCR5 117.28 
GPR35 108.01 GPR141 87.06 MRGPRF 98.36 CCR6 109.41 
GPR37 116.41 GPR142 320.78 MRGPRG 107.04 CCR7 70.12 
GPR45 118.93 GPR143 121.50 MRGPRX1 79.86 CCR8 111.60 
GPR50 134.19 GPR150 91.57 MRGPRX2 76.74 CCRL2 126.35 
GPR52 92.00 GPR152 102.72 MRGPRX3 146.27 CD97 101.64 
GPR55 118.14 GPR156 108.99 MRGPRX4 150.01 CMKLR1 90.49 
GPR56 130.35 GPR157 98.02 RXFP1 76.87 CX3CR1 105.89 
GPR61 130.76 GPR158 166.57 RXFP2 147.83 CXCR1 111.50 
GPR63 133.15 GPR160 111.66 RXFP3 118.72 CXCR2 114.56 
GPR64 154.80 GPR161 111.91 RXFP4 157.24 CXCR3 97.31 
GPR65 120.57 GPR171 179.72 NPBW1 74.40 CXCR4 117.57 
GPR75 130.21 GPR173 129.56 NPBW2 118.71 CXCR5 112.26 
GPR78 107.35 GPR174 78.17 NPFF1 65.46 CXCR6 168.99 
GPR82 115.84 GPR182 149.48 NPFF2 75.08 FFA1 105.18 
GPR83 105.56 BBA3 97.41 OPN5 106.91 FFA2 103.09 
GPR84 115.82 C5A 75.63 OXGR1 107.12 GPBA 110.75 
GPR87 105.22 CCR10 130.98 PKR1 102.71 GPER 110.93 
GPR92 116.29 ELD1 126.05 PKR2 70.67 GAL3 98.13 
GPR97 97.55 FPR3 99.43 PRRP 76.54     
GPR101 99.93 GPRC5A 187.08 QRFP 105.65     
Table 4.1: Percentage RLU for screened orphan GPCRs  
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HTL cells transfected with 126 human orphan GPCRs from class A, B, or C. Cells 
were treated with 0 or 1mM fluoride and relative luminescence units (RLU)  were 
measured to calculate %RLU calculated using formula %RLU= RLU from fluoride 
treated wells/ RLU from fluoride untreated wells (IUPHAR class A database; 
IUPHAR class B database; IUPHAR class C database). 
  
GPCR Class Human Chr. (AA) Mouse Chr. (AA) % RLU 
GPR142 Class A 17q23 (462) 11 E2 (365) 321 
GPR111 Class B 6p12.3 (642) 17 B3 (644) 259 
GPRC5D Class C 12p13.3 (300) 6 G1 (345) 226 
Table 4.2: Orphan GPCRs activated by fluoride 
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4.5 Discussion 
GPCR’s forms the largest family and pharmacologically diverse group of 
mammalian membrane bound proteins. About 1/3rd of the known drugs target GPCR 
functions which suggest the importance of GPCRs in therapeutics. (Tang et al., 
2012). GPCRs are of great interest due to its unique property to transduce 
extracellular signal into intracellular signaling events through heterotrimeric G 
proteins. GPCRS binds to a wide range of ligands including ions, small peptides, 
and organic compounds (Vardy and Roth, 2013). Phylogenetically human GPCRs 
are categorized in to five main families such as; Rhodopsin, Glutamate, Adhesion, 
Secretin, and Frizzled/Taste 2. Rhodopsin forms the largest family of GPCRs 
members of which are widely studied (Tang et al., 2012). 
Deorphanization of the orphan GPCRs can be challenging due to lack of 
knowledge about the functionality and ligand specificity of these orphan receptors.  
(Chung et al., 2008). Part of the challenge arises due to that fact that most 
deorphanation assay involves detection of changes in the levels of second 
messengers (canonical pathway). However, it is important to understand that levels 
of the second messengers are regulated by the heterotrimeric G proteins and can be 
independent of GPCR of interest. Similarly lack of knowledge about intracellular 
signaling after orphan GPCR activation potentially limits the selection of proper 
positive and negative controls. The β-arrestin recruitment assay (non-canonical 
signaling) is independent of intracellular second messengers (Barnea et al., 2008), 
which distinguishes the β-arrestin recruitment assay from other assays that measure 
GPCR function.  
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In the β-arrestin recruitment assay an orphan receptor is genetically modified to 
transduce an intracellular signal into a reporter gene transcription. Transcriptional 
activation of reporter gene provides a quantitative measure for GPCR activation. The 
reporter gene activity is independent of endogenous receptors and hence β-arrestin 
recruitment assay is sensitive (Allen et al., 2011). 
 
Figure 4.5: Schematic of the β-arrestin recruitment assay 
In the β-arrestin recruitment assay when a genetically modified GPCR (with attached 
transcription factor via protease site) binds to its ligand it leads to the recruitment of 
the arrestin-TEV protease fusion. Proteolytic cleavage at protease site liberates the 
tethered transcription factor (tTA). The tTA translocates to the nucleus leading to 
transcription of reporter gene. Increase in the reporter gene activity is used as a 
quantitative measure for receptor activation (Barnea et al., 2008). 
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The β-arrestin recruitment assay monitors ligand binding-mediated receptor 
activation (non-canonical pathway). We screened human CASR and orphan GPCRs 
using this generality to identify receptor activation by fluoride through β-arrestin 
recruitment assay which provides a more quantitative assay, unaffected by 
endogenous receptor signaling (Tohgo et al., 2003).  
Fluoride is known to activate various G-proteins, including the two regulatory 
proteins Gs and Gi of the AC system (Sternweis and Gilman, 1982). Fluoride mimics 
the effects of high calcium on several intracellular second messengers to mediate a 
time- and dose-dependent increase in the accumulation of IP3 in bovine parathyroid 
cells (Chen et al., 1988).  
Fluoride does not influence β-arrestin recruitment by CASR in HTL cells which 
suggests that actions of fluoride on parathyroid gland to modulate PTH secretion 
(non-canonical pathway) are independent of CASR. Altering the calcium 
concentration did not have any impact on the fluoride-mediated arrestin recruitment 
which further supports our finding. There was a difference in β-arrestin recruitment 
based on difference in media calcium concentration. The role of media calcium 
concentration on CASR signaling has been previously documented (Roussanne et 
al., 2001). High media calcium increased arrestin recruitment and thereby 
luminescence readout. In our study 0mM calcium in the media demonstrated 
maximum arrestin recruitment which is in accordance with previously reported 
findings (Almaden et al., 2009; Nemeth et al., 1998). These findings suggests that 
increase in arrestin recruitment may be is responsible for a low extra-cellular calcium 
mediated increase in the PTH secretion (non-canonical pathway).  
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The IC50 concentration (1-2mM) determined in our experiments with R568 are 
comparable to those in previously documented study (Li et al., 2009). However 
Nemeth el al reported much lover IC50 values (~27nM) compared to our values 
(Nemeth et al., 1998). It is interesting to note that using arrestin recruitment assay in 
our study, R568 demonstrated an inverse agonist activity on CASR rather than 
positive allosteric modulator activity as previously described (Li et al., 2009; Nemeth 
et al., 2004; Wada et al., 2000). Our study demonstrated that the activity of R568 
was specific for CASR and also extended to other known calcium sensing receptor 
such as GPRC6A. 
Three orphan receptors identified by the β-arrestin assay: GPRC5D, GPR111 
and GPR142 (Brauner-Osborne et al., 2001; Fredriksson et al., 2003), which were 
activated by fluoride treatment, are ubiquitously expressed. However, functional 
aspects of these three GPCRs are unknown. In a study by Everett et al to determine 
genetic basis for fluoride susceptibility in two strains of mice (A/J and 129P3/J) 
detected quantitative trait loci (QTLs) associated with dental fluorosis on 
chromosome 2 and 11(Everett et al., 2011). It is interesting to know that in mice 
GPR142 is localized on chromosome 11. Therefore, future studies will be directed to 
identify the role of GPR142, GPR111 and GPRC5D in fluoride mediated actions on 
hard tissues to understand the patho-physiology of dental and skeletal fluorosis.  
The findings of the study can be summarized as follows: Fluoride can modulate 
PTH secretion independent of CASR activation. The possibility of involvement of 
other GPCRs in fluoride-mediated modulation of PTH cannot be rejected. Screening 
of the orphan GPCRs for fluoride-mediated receptor activation identified three 
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candidates: GPRC5D, GPR111, and GPR142. Future study of these candidates will 
help us to understand their role in the patho-physiology of dental and skeletal 
fluorosis and fluoride’s action on cellular biology. 
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